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                                                        ABBREVIATION 
AGA             -  Antigliadin antibodies 
Anti-tTG       -  Antibodies to tissue transglutaminase 
BHR              -  Bronchial hyper-responsiveness 
CBC               -  Complete Blood Count 
CGRP            - Calcitonin Gene Related Peptide  
cds                  - Coding sequences 
EMA              -  Endomysial antibodies 
FOBT             -  Fecal occult blood test 
HPA               -  Hypothalamic-pituitary-adrenal axis 
IBS                 -  Irritable bowel syndrome 
IBS-D             -  Diarrhea-predominant IBS 
IBS-M            -  Mixed IBS 
IBS-C             -  Constipation-predominant IBS 
IBD                -  Inflammatory bowel disease 
PG                  -  Prostaglandin 
RFLP              - Restriction Fragment Length Polymorphism            
SIBO              -  Small Intestinal Bacterial Overgrowth 
HRQoL          - Health-Related Quality of Life. 
 TSH               - Thyroid Stimulating Hormone 
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Irritable bowel syndrome (IBS) is a functional disorder that affects 10% to 20% of the 
population worldwide .1-3 IBS is characterized by altered bowel habits and abdominal 
discomfort in the absence of organic disease. No clear diagnostic markers exist for IBS and 
thus diagnoses are based on the clinical presentation. A relationship between irritable bowel 
syndrome (IBS) and broncho-pulmonary disease was initially suspected in 1991, when White 
and co-workers4
 
reported bronchial hyper-responsiveness to be more frequent in patients with 
IBS. Further, Kennedi and colleagues showed an association between symptoms of IBS and 
those of bronchial hyper-responsiveness.5 Amra et al reported that patients with IBS have 
increased airway resistance as compared to healthy subjects, as measured by impulse 
oscillometry.6 Two independent results showed
   
bronchial asthma may be more prevalent in 
IBS patients than in otherwise healthy subjects.7,8 Chan et al reported  PTGS2.8473 
polymorphism is associated with asthma, atopy and lung function.9 Sanak et al reported 
increased production of prostaglandins in bronchial asthma in association with T→C transition 
within the 3′-untranslated region (COX2.8473).10 
               Serotonin ( 5-HT) is secreted in copious amounts from gut enteroendocrine cells 
and serves as a critical messenger for gastrointestinal fluid secretion and gut motility11,12. 
There are seven subclasses of serotonergic receptors, differentiated on the basis of structure, 
molecular mechanism, and function.13 The 5-HT1A receptor is a G protein-coupled receptor 
that is coupled to Gi/Go and mediates inhibitory neurotransmission.Activation of serotonin 5-
HT1A receptor in the enteric nervous system suppresses gut motility.14,15 Clarke et al reported 
marked elevations in proinflammatory polyunsaturated fatty acid metabolites like PGE2  in 
females with Irritable Bowel Syndrome.16 Kenda et al showed the responsiveness of the 5-
HT1A receptor system was reduced by a cyclooxygenase-dependent metabolite of AA.17   
                        In this study, the association of COX2.8473 T→C single nucleotide 
polymorphism (SNP ) with IBS  was investigated. 
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Irritable bowel syndrome (IBS) is a functional gastrointestinal (GI) disorder characterized by 
abdominal pain or discomfort and altered bowel habits18,19. As such, IBS occurs in the 
absence of identifiable physical, radiologic, or laboratory indications of organic disease19,20. 
Characterized as a “brain–gut disorder,”21 IBS is associated with such altered physiologic 
processes as changes in gut motility22,23 visceral hypersensitivity24 and altered immune 
activation of the gut mucosa and intestinal microflora25. IBS has a reported prevalence of 5%-
10% in most of Asia 26. Although IBS is characterized with abdominal pain and altered bowel 
activity, it lacks any pathological organic changes. The IBS group was subdivided (Table 1) 
into diarrhea predominant (IBS-D), constipation predominant (IBS-C), mixed with diarrhea 
and constipation (IBS-M), or undetermined categories (IBS-U) according to the bowel 
movement frequency and stool consistency.  
                                                             
               Generally, race27, gender28-31,age2,32,33, marital status34,35, stress28-30,34-37,food1,32,35,38, 
or alcohol and tobacco32 use have been considered as risk factors to IBS. IBS accounts for 
significant health care resource utilization and economic burden. Direct costs are often high 
in the initial diagnostic phase as historically IBS has been considered a diagnosis of 
exclusion, prompting sequential testing and invasive procedures in an attempt to identify 
organic GI disease.19,20,39. Dean et al40 found that IBS-related symptoms reduced work 
productivity by an estimated 21% per week thus increasing costs to employers. Because IBS 
is not a mortal illness, the impact on patients is often underestimated. In reality, however, IBS 
patients have substantially poorer health-related quality of life (HRQoL) than the general 
population and HRQoL that is on par with that seen in diabetes, depression, and 






1. IBS with constipation (IBS-C): hard or lumpy stools ≥25% and loose (mushy) or watery      
 stools <25% of bowel movements 
 
 
2. IBS with diarrhea (IBS-D)      : loose (mushy) or watery stools ≥25% and hard or lumpy  
                                                     stools <25% of bowel movements 
 
 
3. Mixed IBS (IBS-M)                : hard or lumpy stools ≥25% and loose (mushy) or watery  
                                           stools ≥25% of bowel movements 
 
 
4. Unsubtyped IBS                     : insufficient abnormality of stool consistency to meet criteria 






Data on the prevalence of IBS : 
 
Table 2 




































      2.9-15.6 No systematic 
evaluation has been 
reported 
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                                   Several sets of criteria have been developed to identify and standardize 
the diagnosis of IBS (Table 3)19,20.The early Manning criteria43 identified six symptoms that 
increase the likelihood of an IBS diagnosis but do not stipulate a required number or duration 
of symptoms. In 1984, Kruis et al44 developed a system of symptoms, physical findings, and 
laboratory results, and in 1990, an international working group45 developed Rome I criteria in 
an attempt to reduce unnecessary testing and provide a uniform framework for selecting 
patients for diagnostic and therapeutic trials in IBS20,46. These criteria were revised in 1999 
by the Rome II working group and again in 2006  by the Rome III working group and again 
in 2006 by the Rome III working group (Table 3)18,47                                                        
Anatomy & Physiology of the Gastrointestinal Tract :                                 
                  The lower gastrointestinal tract is divided into five parts: the caecum, the 
ascending colon, the transverse colon, the descending colon, and the rectum. The large 
intestine (colorectum) begins at the caecum, which is approximately 2–3 inches long and 
shaped like a pouch. Ileal contents empty into the cecum through the ileocecal valve. The 
appendix extends from the base of the cecum. The ascending colon rises from the caecum 
along the right posterior wall of the abdomen, under the ribs to the undersurface of the liver. 
At this point it turns toward the midline (hepatic flexure), becoming the transverse colon. The 
transverse portion crosses the abdominal cavity toward the spleen, then goes high up into the 
chest under the ribs, and turns downward at the splenic flexure. Continuing along the left side 
of the abdominal wall to the rim of the pelvis, the descending colon turns medially and 
inferiorly to form the S-shaped sigmoid (sigma-like) colon. The rectum extends from the 
sigmoid colon to the pelvic floor muscles, where it continues as the anal canal terminating at 


















The large intestine, the site of salt and water absorption, is approximately 5–6 feet long and 
about 2½ inches in diameter. It is the site of salt and water absorption. Glands secrete large 
quantities of alkaline mucus into the large intestine, and the mucus lubricates intestinal 
contents and neutralizes acids formed by bacteria in the intestine. These bacteria aid in 
decomposition of undigested food residue, unabsorbed carbohydrates, amino acids, cell 
debris, and dead bacteria through the process of segmentation and putrefaction. Short-chain 
fatty acids, formed by bacteria from unabsorbed complex carbohydrates, provide an energy 
source for the cells of the left colon. Maintenance of potassium balance is also assigned to the 
colon, where the epithelium absorbs and secretes potassium and bicarbonate.  
             The sympathetic and parasympathetic nervous systems innervate the gastrointestinal 
tract Both carry sensory stimuli, though it appears that spinal affrent nerves in the dorsal horn 
of the spinal cord process pain                                                                                             
                        The physiology of sensation in the gut is multifaceted. Enteroendocrine cells 
transmit mechanical and chemical messages. The communication between gut and brain 
results in reflex responses mediated at three levels—prevertebral ganglia, spinal cord and 
brainstem.   5-HT, substance P, CGRP, norepinephrine, kappa opiate and nitric oxide are all 
involved in the perception and autonomic response to visceral stimulation. Sensation is 
conveyed from the viscus to the conscious perception via neurons in vagal and 
parasympathetic fibers (Figure 2). Afferent nerves in the dorsal root ganglion synapse with 
neurons in the dorsal horn. These signals result in reflexes that control motor and secretory 
functions as they synapse with efferent paths in the prevertebral ganglia and spinal cord. Pain 
is processed through spinal afferents in the dorsal horn. Ultimately, stimulation of the 
brainstem brings sensation to a conscious level. Bidirectional signaling between the 
brainstem and the dorsal horn mediate sensation. The descending pathways are primarily 
adrenergic and serotonergic and affect incoming stimuli. End organ sensitivity, stimulus 
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intensity changes or receptive field size of the dorsal horn neuron and limbic system 
modulation are the mechanisms involved in visceral hypersensitivity. 
Normal flora and host defences: 
                          The normal gut is host to several kilograms of bacteria, most of which reside 
in the colon. Bacterial counts in the stomach number 101–2 colony-forming units (cfu)/ml, 
while in the jejunum 103–4 cfu/ml, largely of pharyngeal organisms, is normal. As one 
progresses toward the ileocecal valve, counts rise, and within the ileum 105–6 is normal. 
However, at the ileocecal valve, there is an abrupt increase in numbers, which rise to 1010–13 
cfu/ml, with a marked change in the nature of organisms, which become anaerobic/facultative 
anaerobic, with coliforms and anaerobes predominating. Throughout the gut, there are 
extensive innate defensive mechanisms, which include both gastric acid, bile, lysozyme, and 
defensins in the upper gut and tight intraepithelial junctions and mucus layers in the lower 
gut. There is also an acquired immunity based on immunoglobulin secretion (mainly IgA) 
and cell-mediated responses. Breaches of these defenses by pathogenic organisms produce 
acute inflammation with release of cytokines and recruitment of circulating inflammatory 
cells. In addition to breaches in the epithelium, there is also extensive damage to the lamina 
propria and submucosa together with the associated nerves. During the process of healing, 
metaplastic changes occur with increases in enteroendocrine cells, Paneth cells, and chronic 
inflammatory cells25. Furthermore, remodeled nerves often show aberrant expression of 
receptors and neuropeptides.48  
Pathophysiology of IBS: 
                            The biopsychosocial model of IBS integrates a number of psychosocial, 
motility, sensory abnormalities and abnormalities in central nervous system processing of 













                    Approximately 40–60% of patients with IBS who seek medical care also report 
psychiatric symptoms, such as depression, anxiety, or somatization. Interestingly, however, 
psychiatric symptoms in patients with IBS in the general population are not as prevalent. It is 
thought that these psychiatric disturbances influence coping skills and illness-associated 
behaviors. A history of abuse (physical, sexual, or emotional) has been correlated with 
symptom severity. More than half of patients who are seen by a physician for Irritable Bowel 
Syndrome report stressful life events coinciding with or preceding the onset of symptoms.  
Neurotransmitters  
                                        IBS patients demonstrate significant differences in pain perception, 
and a variety of perceptual abnormalities related to gastrointestinal stimuli may be more 
frequent in irritable bowel sufferers. This sensitivity develops as a result of visceral 
hyperalgesia. Studies evaluating somatic stimuli have demonstrated that the lower tolerance 
for pain in patients with IBS occurs primarily in the bowel. Recent studies associate 
neurotransmitters with IBS. Serotonin is located in the central nervous system (5%) and the 
gastrointestinal tract (95%), and when it is released into the body it results in the stimulation 
of intestinal secretion and peristaltic reflex (Figure 4) and in symptoms such as abdominal 
pain, bloating, nausea, and vomiting. These preliminary studies suggest increased serotonin 
levels in the plasma and in the rectosigmoid colon of patients with IBS.   
Stress and Irritable bowel syndrome: 
                          Stress, defined as an acute threat to the homeostasis of an organism, real 
(physical) or perceived (psychological) and posed by events in the outside world or from 
within, evokes adaptive responses that serve to defend the stability of the internal 
environment and to ensure the survival of the organism. Numerous reports in the literature 
provide evidence for a prominent role of stress in the pathophysiology and clinical 
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presentation of IBS symptoms49. Various stressors induce characteristic changes in 
gastrointestinal motor function. Moreover, manipulation of attention and changes in arousal 
level produced by stress, distraction, and relaxation has been reported to alter visceral 
perception. Different types of stressors play a role in 1) permanent enhancement of stress 
responsiveness (pathological stress), 2) transient symptom exacerbation, and 3) symptom 
perpetuation (symptomgenerated stress). Early life stress and trauma, in the form of abuse, 
neglect, or loss of the primary caregiver, play a major role in the vulnerability of individuals 
to develop functional gastrointestinal (GI) disorders later in life. Acute, life-threatening stress 
episodes in adult life (rape, posttraumatic stress syndrome) are also important risk factors in 
the development of functional GI disorders. In the genetically predisposed individual, both 
early life stress and severe life-threatening stress (referred in this article as “pathological 
stressors”) can result in permanent, irreversible enhancement of the responsiveness of central 
stress circuits and therefore vulnerability to development of functional (as well as affective) 
disorders later in life. Other types of stressors occurring throughout the life of an individual, 
which may result only in transient changes in stress responsiveness, clearly play a role in 
symptom exacerbation. For example, psychosocial stressors in the form of sustained, 
threatening life events have been associated with onset and symptom exacerbation in IBS. 
“Physical” or interoceptive stressors of the digestive system, such as enteric infections, 
trauma, and surgery, may play a similar role in symptom exacerbation in the predisposed 
individual. Finally, in the affected patient, fear conditioning and interoceptive conditioning 
are likely to play important roles in triggering stress responses to situations and contexts that 
by themselves are not threatening or stressful. For a large number of IBS patients, the 
positive-feedback loop of conditioned fear responses to interoceptive stimuli or contextually 
conditioned stimuli of symptom-generated stressors may play a primary role in symptom 
chronicity. 
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                              The traditional concept of stress has focused on the subjective conscious 
feelings, thoughts, beliefs, and memories reported by some individuals in association 
with stressful life events. However, the major breakthroughs in this area have occurred 
through an under- standing of the biological mechanisms that are responsible for the 
detrimental effects of certain stressful life events on health. The organism’s response to 
stress is generated by a network comprised of integrative brain structures, in particular, 
subregions of the hypothalamus (paraventricular nucleus, PVN), amygdala, and 
periaqueductal gray. These structures receive input from visceral and somatic afferents and 
from cortical structures, in particular, the ventral subdivision of the anterior cingulate and the 
medial prefrontal (ventromedial and orbitofrontal) cortex .This integrative network provides 
outputs to the pituitary and to pontomedullary nuclei, which in turn mediate the 
neuroendocrine and autonomic output to the body, respectively. This central stress circuitry is 
under feedback control via ascending monoaminergic projections from these brain stem 
nuclei, in particular, serotonergic (raphe nuclei) and noradrenergic (NA) (including locus 
ceruleus) nuclei, and via circulating glucocorticoids, which exert an inhibitory control via 
central glucocorticoid receptors located in the medial prefrontal cortex and hippocampus .The 
parallel outputs of this central circuitry (“emotional motor system,” EMS), which is activated 
in response to various stressors, include responses of the autonomic nervous system, the 
hypothalamic-pituitary-adrenal (HPA) axis, endogenous pain modulatory systems, and 
ascending aminergic pathways. One important chemical mediator of the central stress 
response is corticotropin-releasing factor (CRF) (and probably related currently unknown 
molecules) located in certain effector neurons of the PVN, the amygdala, and the locus 
ceruleus complex . CRF secretion by PVN neurons is under positive- feedback regulation by 
central NA pathways (including those originating from locus ceruleus), thereby forming a 
bidirectional positive-feedback loop between the CRF and NA systems. Central injection of 
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CRF can reproduce behavioral and physiological responses similar to those seen in response 
to acute psychological stress , and inhibition of CRF-mediated responses by antagonists or in 
knockout animals results in a decrease in the animals’ response to stress50,51  
Enhanced responsiveness of central stress circuits: 
         The responsiveness of the EMS is likely to be under partial genetic control, and it 
shows considerable plasticity in response to early life events and to certain types of 
pathological stress . For example, studies in animals and humans clearly demonstrated that 
certain types of pathological stress can alter the responsiveness of feedback systems by 
downregulation of preand/ or postsynaptic receptors [adrenergic, serotonergic, 
glucocorticoid receptors (GC)] and, in the most severe forms, by structural changes in certain 
brain regions52. Thus pathological stress can not only activate but also fundamentally change 
the responsiveness and output of the central stress circuits. These alterations could affect the 
individual output pathways of the EMS differentially and in different directions, for example, 
an increase or decrease in target-specific sympathetic and vagal outputs, up- or 
downregulation of the HPA axis, and up- or downregulation of pain perception. Some of the 
best-characterized alterations in this central adaptation to pathological stress are an increase 
in CRF synthesis and secretion, an increase in the activity and sensitivity of central NA 
systems, and downregulation of GC  suggestive of an enhanced HPA response to stress. In 
contrast, an upregulation of GC has been found in animals exposed to “early handling” stress 
and in patients with posttraumatic stress disorder (PTSD), which supports an enhanced 
negative-feedback control of cortisol and a blunted HPA response to stress. As a consequence 
of these alterations in the central stress circuitry, secondary changes in receptor systems can 
occur in spinal or peripheral target cells of the output systems. Thus, in cases of pathological 
stress resulting in permanent changes in the central stress circuitry, lifelong changes in 
22 
peripheral receptor systems may also be expected. In  the following paragraphs, we discuss 
evidence for alterations in the three output systems of the EMS in IBS patients. 
Changes in autonomic nervous system responses: 
                            In the most common functional GI disorders, IBS and functional dyspepsia 
(FD), persistent alterations of autonomic responsiveness are likely to play a role in altered 
bowel habits and alterations in gastric emptying, respectively. Evidence for such enhanced 
responsiveness of autonomic responses in IBS  includes increased responses of distal colonic 
motility in response to laboratory stress and possibly food intake and delayed gastric 
emptying in a subset of patients. A model of IBS, taking into account altered autonomic 
regulation of gastric and distal colonic function and based on an upregulation of CRF-
containing neurons in Barrington’s nucleus (part of the locus ceruleus complex), was recently 
reported by Valentino and co-workers 53. Although descending CRF-containing projections 
from this pontine nucleus to the distal colon may mediate increased stress- and food-induced 
motor  responses of the distal colon, ascending projections to the locus ceruleus and to the 
forebrain may be responsible for mediating arousal and shifting attention to visceral afferent 
stimuli. Increased expression of CRF message and release of CRF in IBS patients, or a subset 
of patients, is also consistent with the reported evidence for certain increased sympathetic 
responses . Changes in the frequency of high-amplitude propagated contraction (HAPC) in 
the colon, presumably via alteration in vagal colonic regulation, may play an important role 
in diarrhea and slow-transit constipation, thereby determining the predominant bowel habit 
pattern in IBS. There is evidence that decreased cardiovagal tone is present in a subset of 
patients with IBS, in particular in female patients with constipation-predominant bowel habit 
and more severe symptoms 54,55. The correlation of changes in cardiovagal tone and vagal 
regulation of the intestine is emphasized by the recent demonstration in patients with 
functional constipation of parallel changes in cardiovagal tone and autonomic regulation of 
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whole gut transit and distal colonic mucosal blood flow . Thus, although enhanced sacral 
parasympathetic modulation of the distal colon, reflecting enhanced responsiveness of 
neurons within the locus ceruleus complex, may be shared by all IBS patients, alterations in 
vagal output to the small intestine and proximal colon may be variable, depending on severity 
and the predominant bowel habit. 
Neuroendocrine changes: 
                               Preliminary evidence for alterations in HPA axis function was 
demonstrated in diarrhea-predominant IBS patients who showed decreased 24 h plasma 
cortisols, blunted cortisol responses, and normal ACTH responses to noxious rectosigmoid 
distension 56. In contrast, Heitkemper et al57 reported that urine cortisol levels obtained 
immediately on rising were significantly higher in a subgroup of IBS women compared with 
control women.Even though a thorough characterization of HPA axis responses in patients 
with functional gastrointestinal disorders has not been reported, these preliminary findings 
suggest the pattern of sensitized GC feedback also reported in patients with PTSD, 
fibromyalgia, and chronic fatigue syndrome. However, HPA responses at baseline and in 
response to provocation in these patients have been conflicting, which may be caused in part 
by methodological differences and the presence of comorbid depression in some patients. 
There is significant overlap in the epidemiology of all these conditions with IBS. Other 
evidence for central alterations in neuroendocrine responses in IBS comes from reports of 
abnormal neuroendocrine challenge tests . Existing data support neuroendocrine alterations in 
IBS and other overlapping syndromes, but further well-designed studies are needed to fully 




Possible relevance of autonomic and neuroendocrine changes for intestinal immune 
modulation:  
                               Although it is not known currently whether these HPA axis changes are 
an epiphenomenon or play a role in symptom generation and pathophysiology of these       
syndromes, one may speculate about their possible role (in conjunction with alterations in 
autonomic gut regulation) in the observed findings in postinfectious IBS patients. The 
reported persistence of chronic inflammatory mucosal changes after eradication of the 
infectious organism and increased intestinal permeability and hyperplasia of 
enterochromaffin cells are consistent with an inadequate physiological response to acute gut 
inflammation, in particular an inadequate cortisol (and possibly an altered sympathetic) 
response. Stress-related alterations in cytokine networks, in particular a suppression of 
cellular immunity and a shift toward humoral immunity [alteration in T helper (Th)1/Th2 
balance], have been reported 58. Multiple reports in the literature on increased intestinal mast 
cell numbers in IBS patients are consistent with such a Th2 shift. 
 Changes in pain modulation: 
                                      Evidence suggestive of alterations in stress-induced modulation of 
viscerosomatic sensitivity comes from human and animal studies. IBS patients show 
cutaneous normo- or hypoalgesia combined with visceral hypersensitivity. A similar pattern 
was also seen in a recently described rat IBS model in response to an acute psychological 
stressor 59. Preliminary results from the use of psychological laboratory stressors in healthy 
volunteers suggest a stress-induced increase in colonic or rectosigmoid sensitivity to 
distension .Even though all published human studies are open to methodological criticism, 
they are consistent with reported findings in animals of a differential viscerosomatic pain 
modulation. It is of interest to note that patients with bulimia (who, in contrast to IBS 
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patients, have a hyperactive HPA axis) show cutaneous hypoalgesia as well, which precedes 
symptom exacerbations.  
Changes in regional brain activation: 
                    Functional brain imaging studies of IBS patients have shown decreased 
activation of ventral subdivisions of the anterior cingulate cortex (ACC) and increased 
activation of the dorsal subdivision60. Because dorsal ACC is inhibited by intense visceral 
stimuli in healthy control subjects , increased dorsal ACC activation may be related to 
alterations in attentional processes in IBS in regard to visceral sensory events. Decreased 
ventral cingulate/medial prefrontal cortex activity was also reported in patients with 
depression and PTSD, both affective disorders commonly associated with IBS. Southwick et 
al61 reported a decrease in prefrontal and orbitofrontal cortical metabolism in patients with 
PTSD in response to the α2-antagonist yohimbine. Together with results from preclinical 
studies showing decreased metabolism in cortical regions with high NA release, these results 
are consistent with enhanced NA release in these brain regions in PTSD patients. One may 
speculate that the decreased activation in ventral anterior cingulate, ventromedial frontal 
cortex, and hippocampus seen in IBS patients may also be related to enhanced NA release 
from locus ceruleus projections in response to stress, consistent with the Valentino model53. 
Recent evidence suggests tha  regional brain activation in response to visceral stimulation 
may differ between male and female IBS patients . Although most brain regions showed 
similar activity patterns in male and female patients, differences were seen primarily in the 
insular and anterior cingulate cortices. 
Corticotropin-releasing hormone (CRH) & IBS 
Corticotropin releasing hormone (CRH) is considered to be a major mediator of stress 
responses in the braingut axis. In particular, stress related activation of CRH receptors has 
been reported to produce alterations in gastrointestinal function. In addition, physical or 
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psychological stress is known to delay gastric emptying, accelerate colonic transit and evoke 
colonic motility in rats 62. Stress is processed in the brain and the signal is conducted to the 
paraventricular nucleus (PVN) of the hypothalamus.63CRH is released in the PVN and 
stimulates adrenocorticotropic hormone (ACTH) secretion from the pituitary gland.64 ACTH 
stimulates the adrenocortex and releases cortisol. At the same time, CRH activates 
sympathetic nervous system and stimulates cardiovascular system 65 CRH also activates 
sacral parasympathetic outflow and stimulates colonic motility.66 Recently, distention of the 
colon is known to activate the CRH system in the brain.67 Therefore, visceral stimulation is 
interpreted as interoceptive stress. Effect of CRH is mediated via CRH receptors in the cell 
membrane of effecter organs. CRH receptor is a seven transmembrane G-protein coupled 
receptor. Activated G-protein stimulates adenylate cyclase and increases intracelluar cyclic 
AMP. CRH receptors are expressed in the various brain regions. They are the cerebral cortex, 
cerebellum, hypothalamus, anterior pituitary, amygdala, hippocampus, locus ceruleus, 
lateralseptum, and others. CRH receptors are also expressed in the peripheral organs.They are 
heart, arterial smooth muscle, lung, spleen, stomach, intestine, adrenal glands, kidney, skin, 
skeletal muscle, testis, ovary, and uterus, and others. In IBS patients, exogenous 
administration of CRH induced robust colonic motility68. Besides, exogenous administration 
of CRH induced exaggeration of ACHT secretion in IBS patients. This finding was replicated 
by Dinan et al.69 
Inflammation of the gut and CRH 
Chronic low-grade inflammation or discrete inflammation of the gut mucosa combined with 
psychosocial stress may trigger the sensitization of the lower gastrointestinal tract in IBS70,71 
Several reports indicated that there is low-grade inflammation of the colonic mucosa in IBS 
patients72,73 Increase in intraepithelial lymphocytes, CD3 positive cells, and CD25 positive 
cells was found in the colonic mucosa of IBS patients. Activated immune system may result 
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in elevated plasma cytokines in the peripheral blood in IBS patients. Dinan et al69 reported 
increase in plasma interleukin-6 level in IBS patients. There was no abnormality in the 
plasma level of TNF-α. Interestingly, the plasma level of interleukin-6 positively correlated 
with the CRH stimulated ACTH level. Some links between macrophage and colonic function 
may be present. Studies by Muramatsu et al.74 proved mRNA of the CRH family peptide 
urocortin and CRH receptors in the human colonic mucosa. The major source of urocortin in 
the human colonic mucosa is macrophages. Furthermore, Wood’s group recently proved the 
existence of CRH immunoreactivity and CRH receptors in the myenteric plexus of the guinea 
pig.75 There are abundant CRH-R1 positive cells in the myenteric neurons. Most of them are 
excitatory neurons which enhance colonic and intestinal motility. Besides, there is some 
evidence that peripheral CRH induces inflammation via an increase in intestinal 
permeability.76 Degranulated mast cells may play a role in the proinflammatory action of 
CRH. On the other hand, CRH-R2 has been proven to have an anti-inflammatory action77 
CRH-R2-deficient mice showed increased paw edema after the exposure to the heat stimuli. 
Besides, CRH-R2 has anti-nociceptive action.78 Administration of CRH-R2 agonist human 
urocortin2 inhibited spinal expression of immunoreactivity of the extracelluar signal-
regulated kinase 1/2 evoked by the colorectal distention in rats. There are functional 
differences between CRH-R1 and CRH-R279  In the brain, R1 stimulation causes anxiety 
whereas R2 stimulation induces anxiolysis. In the gut motility, R1 stimulation evokes colonic 
motility whereas R2 stimulation inhibits gastric emptying. R1 mediates visceral nociception 
whereas R2 may reduce visceral perception. Finally, activation of CRH-R1 causes 
proinflammatory response, whereas stimulation of CRH-R2 provokes anti-inflammatory 




       Other theories concerning IBS associate the inflammation of enteric mucosa or neural 
plexuses with symptoms. It is hypothesized that inflammatory cytokines may activate 
peripheral sensitization or hypermotility. One group of researchers was able to predict the 
development of IBS in patients with infectious enteritis in the presence of stressful life events 
and hypochondriasis. Researchers in Ontario recently demonstrated that post infection 
inflammation (Trichomonas spiralis) alters visceral sensitivity. In this particular study, NIH 
Swiss mice were infected with T spiralis. Six days after infection the mice experienced 
jejunal enteritis, which returned to normal after 28 days. Using a latex balloon placed in the 
distal colon, investigators found hyperalgesic sensory response following distension that 
persisted despite the lack of acute inflammation.  Rapid small bowel and colonic transit times 
have been reported in patients with diarrhea-predominant IBS. Patients with constipation-
predominant IBS may have a component of disordered defecation, resulting, at least in part, 
from abnormal function of the pelvic floor and anal sphincter muscles. Another factor in 
motor dysfunction is the abnormal passage and handling of gas.  
                 Colonic and rectal hypersensitivity (also called “visceral hyperalgesia”) are also 
important factors in the causation of symptoms. Enteric propulsion and sensation are, in part, 
mediated by acetylcholine and serotonin (5HT). A number of studies have reported 
accelerated small bowel and colon transit as well as exaggerated bowel motility patterns in 
those with diarrhea predominant IBS (IBS-D)80-83. Likewise, several studies have report 
delayed bowel transit in those with constipation predominant IBS (IBSC).80,82 Visceral 
hypersensitivity to mechanical distension can often be identified in IBS patients.24,84-86 
Unfortunately, visceral hypersensitivity does not occur commonly enough to be considered a 
biomarker of IBS87. There is recent evidence to suggest central dysregulation of emotional 
arousal and pain modulation in IBS.88,89  
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Integrative model of Irritable Bowel Syndrome (IBS)  pathophysiology:                           
    IBS   can develop from centrally dominant factors such as 
stress or luminal factors like dysbiosis triggering an altered immune response. Stress alters 
gastrointestinal motility mediated through the hypothalamicpituitary-adrenal (HPA) axis, and 
these motility abnormalities can modify the microbiota with the subsequent immune 
activation in the mucosa and stimulation of nerve terminals, generating symptoms of IBS. On 
the other hand, dysbiosis related to gastrointestinal infections, small intestine bacterial 
overgrowth or antibiotics may increase the epithelial permeability leading to contact between 
pathogens-associated molecular patterns (PAMPs) and toll-like receptors (TLRs) in the 
deeper layers of the gut with the subsequent host immunity response and IBS generation or 
symptom exacerbation90 . 
  Clinical presentation                             
           The hallmark clinical feature of IBS is abdominal pain associated with changes in 
bowel habits.18 Patients with symptoms consistent with constipation-predominant IBS may 
describe bloating, feelings that their bowel is being incompletely evacuated, and straining, 
whereas those with the diarrhea-predominant form typically report abdominal pain, gas, 
urgency, and loose stools, with more than 30% experiencing loss of bowel control.91-93 The 
typical patient is a young woman with abdominal discomfort that is relieved by passage of 
multiple loose liquid stools. Her symptoms will have been present for more than 3 months 
and may be exacerbated by factors such as fatty foods or stress. Typically, no alarm features 
of organic disease, such as unintentional weight loss or rectal bleeding, are present. The 
clinical course of IBS is chronic although symptoms are extremely variable and fluctuate 
over time94. Nearly half of IBS patients report experiencing daily episodes, whereas about 
75% experience at least two episodes per week92. Symptoms of IBS may overlap with 
symptoms found in other disorders, such as chronic constipation, functional dyspepsia, 
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gastroesophageal reflux disease, inflammatory bowel disease (IBD), celiac disease, and 
lactose intolerance95,96. IBS can coexist with other functional disorders, most notably 
fibromyalgia, chronic fatigue syndrome, temporomandibular joint disorder, and chronic 
pelvic pain97,98,and psychological conditions, such as anxiety, symptom-related fears, and 
somatization.21,97,99. The differential diagnosis of IBS can be broad20 and may include IBD, 
colorectal cancer, enteric infections, systemic hormonal disturbances, and diseases associated 
with malabsorption.19 Alarm features that have traditionally increased suspicion for organic 
disease include rectal bleeding, weight loss, iron deficiency anemia, nocturnal symptoms, and 
a family history of such organic diseases as colorectal cancer, IBD, and celiac disease19,99 
.However, with the exception of anemia and weight loss, which have good specificity for 
organic disease, most alarm features have poor overall accuracy for organic pathology, 
including colorectal cancer19,100. Evidence indicates that sequential testing is unlikely to 
uncover the underlying GI organic disease in patients without “alarm features,”19,101,102and 
both the American Gastroenterological Association (AGA) and American College of 
Gastroenterology (ACG) recommend using accepted symptom-based diagnostic criteria to 
make a positive diagnosis of IBS rather than an exhaustive diagnostic investigation19,46,99 
             Clinical observations indicate that a subset (about 10–25%) of the subjects exposed 
to enteric infections in an individual or a community setting go on to develop predominantly 
the symptoms of diarrhea-predominant IBS (IBS-D).70,103-108  PI-IBS is characterized by the 
acute or new onset of symptoms in the presence of previously normal bowel function.72 In 
individuals with PI-IBS, abnormal bowel habits typically persist continuously after the acute 
infectious episode, although they may wax and wane. Although the severity of symptoms 
diminishes, compared with that during the acute infectious episode, bowel function before the 
episode is not regained. Weight loss and bleeding with defecation, which may occur during 
the acute diarrheal episode that precipitates PI-IBS, do not characterize PI-IBS. Persistent 
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weight loss and/or rectal bleeding should stimulate investigation of alternative diagnoses. 
Experimental evidence suggests that chronic inflammation following acute bacterial infection 
has a pathophysiological role in the development of PI-IBS. Subjects with PI-IBS appear to 
be unable to down-regulate intestinal inflammation. In a recent study of unselected patients 
with IBS, there was a decreased prevalence of the anti-inflammatory cytokines IL-10 and 
transforming growth factor– β among these patients, which implies that they were more 
susceptible to prolonged and severe inflammation. Markers of mucosal inflammation are 
consistently elevated in patients with PI-IBS. Both during and 3 months after an episode of 
acute gastroenteritis, the inflammatory cy-tokine IL-1β was present in higher levels in the 
rectal mucosa of 8 patients who developed PI-IBS, compared with 7 patients whose bowel 
habits returned to normal.109 Moreover, at the 3-month assessment, IL-1 β levels were 
elevated in the patients with PI-IBS, but not in the patients whose bowel habits normalized 
after acute gastroenteritis, compared with 18 control subjects who had not had gastroenteritis 
for at least 2 years before the study. On the basis of these findings, the authors suggest that 
inflammation plays a role in causing PI-IBS and that patients who develop PI-IBS may be 
more susceptible to inflammatory stimuli than those who do not. 109 The results of 
macroscopic and conventional histological assessments of the intestinal mucosal of patients 
with PI-IBS generally appear to be normal within 2 weeks of the acute infectious illness, but 
chronic inflammation as revealed by quantitative histological analysis persists.25,72 In a study 
of 21 patients who had experienced acute Campylobacter enteritis and 12 control subjects 
with no bowel symptoms after Campylobacter enteritis, numbers of intraepithelial T 
lymphocytes and enterochromaffin cells in rectal biopsy specimens were elevated, compared 
with cell counts in control subjects, at 2, 6, and 12 weeks after the episode of enteritis .In a 
subset of 7 patients who had symptoms for 1 year after the episode of enteritis, counts of both 
cell types remained significantly higher than those noted for control subjects. Intraepithelial T 
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lymphocytes and enterochromaffin cells were also increased in a separate group of 10 
patients with PI-IBS. Cell counts in the latter group were comparable to those in the 7 
patients who had symptoms 1 year after the episode of Campylobacter enteritis. 25 These 
signs of persistent local inflammation were accompanied by increased small-bowel 
permeability, as reflected by an elevated ratio of urinary excretion of lactulose to mannitol. 
Together, the increases in T lymphocytes and enterochromaffin cells and in small-bowel 
permeability reflect persistent mucosal inflammation. These findings are corroborated by 
results of a study of 28 patients with newly diagnosed PI-IBS after Campylobacter infection, 
28 age- and sex-matched control subjects who were asymptomatic after Campylobacter 
infection, and 34 healthy volunteers110. Enterochromaffin cell counts and T lymphocyte 
counts in rectal biopsy specimens were higher in patients with PI-IBS than in either recovered 
control subjects or healthy volunteers. 110 Enterochromaffin cell hyperplasia, which is thought 
to be a relatively nonspecific response to mucosal injury and inflammation, possibly 
contributes to the symptoms of PI-IBS through serotonin-mediated effects.72 
Enterochromaffin cells are the source of nearly all intestinal mucosal serotonin, which 
stimulates enteric secretions, activates visceral sensory afferents, and mediates peristalsis.   
Why  only less than a quarter of the subjects exposed to enteric infections develop the chronic 
symptoms of IBS has remained an enigma. However, two major risk factors that predispose 
the individuals to develop postinfectious IBS (PIIBS) symptoms following an enteric 
infection have emerged. 1) The duration of enteritis lasting greater than 3 wk significantly 
increases the risk for developing PI-IBS over a duration lasting less than 1 wk. 2) The 
presence of comorbid psychiatric disorders or a lifetime history of anxiety and depression at 
the time of infection increases the risk of developing PI-IBS. The longer duration of enteritis 
reflects its severity of inflammation.70,107 The psychosomatic disorders represent 
dysregulation/ impairment of the central nervous system.104,111 Stress resulting from 
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psychological trauma or physical insult in early stages of life is known to result in persistent 
neural disorders in adulthood. Therefore, early life stress has been used extensively to 
investigate major depressive disorders and posttraumatic stress disorders112. More recently, 
neonatal maternal separation113-115 and colonic irritation116 have been used to model visceral 
hypersensitivity in response to colorectal distension. The immaturity of the stress response 
system in neonates is, therefore, a risk factor for the development of persistent adverse effects 
later in life. However, the molecular mechanisms of persistent cellular dysfunction long after 
the neonatal insult remain unknown. 
 
Traditional diagnostic tests for IBS 
         The traditional diagnostic work-up of IBS includes common tests that may be helpful in 
differentiating IBS with alarm features of organic disease although they are not recommended 
in patients with typical IBS symptoms who do not have alarm features20,99,117. The choice of 
test is usually guided by the nature and severity of symptoms and the patient’s expectations 
and concerns.19 Advantages and disadvantages of these traditional tests are summarized in 
Table 4 . Newer diagnostic tools, such as the examination of stool forms, fecal inflammatory 
markers, and the use of serum biomarker, may be useful adjuncts to traditional evaluations of 
patients with suspected IBS. These simple tests may allow clinicians to distinguish IBS from 
non-IBS disorders in a cost-effective manner,118,119 possibly facilitating a paradigm shift from 
approaching IBS as a diagnosis of exclusion to one of inclusion118. Already used routinely in 
some European countries120, fecal calprotectin and lactoferrin are highly sensitive and 
specific for intestinal inflammation and can differentiate IBD from IBS.96,121. Recently, an 
IBS diagnostic panel composed of 10 serum biomarkers that are linked to multiple regulatory 
pathways and proteins associated with IBS has been developed.  
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Table  4 
 
         Tests 
 
 
       Advantages 
 
      Disadvantages 
 





Limited value in identifying 
organic disease in patients 




Stool for ova and parasites 
 
Noninvasive, inexpensive 
May be useful in patients with 
clinical features, symptom pattern, 
and geographic area suggestive of 
infection49 
 
Limited value in identifying 
organic disease in patients 
without alarm features19 
 
 
Hydrogen breath tests 
 
 
May be useful when lactose 
maldigestion is suspected 74,75 
Noninvasive 
 
Need for specialized equipment, 
dedicated space, and technical 
support74 
 False-positive results possible 
in smokers and those with poor 
oral hygiene74  
Limited value in identifying 
organic disease in patients 








Routine use in IBS-D and IBS-M 









May be useful in excluding 
mechanical obstruction in patients 
with IBS-C and alarm features19 
 
Expensive 
Low diagnostic yield in patients 








Useful for identifying organic 
diseases (particularly IBD, colorectal 
cancer, and microscopic colitis) in 
patients with IBS-D and alarm 
features19 Can exclude mechanical 
obstruction in patients with IBS-C 
and alarm features19 
Upper endoscopy with biopsies may 





Low diagnostic yield in patients 
without alarm features20,77 
Normal findings not associated 
with improved HRQoL 78 
Burbige, E.J., Irritable bowel syndrome: diagnostic approaches in clinical practice79 
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Routine blood and stool hemoccult tests  
                                              The AGA recommends a screening of complete blood count and 
stool hemoccult for patients presenting with IBS symptoms of short duration, family history 
of colorectal cancer or IBD, older age at symptom onset, or lack of concurrent psychosocial 
difficulties99. However, these tests offer little value in identifying organic disease in patients 
with typical IBS symptoms but no alarm features. Further, a causal relationship between the 
thyroid dysfunction and IBS symptoms was not established.19 Stool examinations for ova and 
parasite stool examinations may be useful if the patients’ symptom pattern, geographic area, 
and clinical features (eg, diarrhea in an area of known endemic infection) suggest an 
infectious etiology99.However, such tests are not recommended for routine use in patients 
without alarm features or infection,19,99 as findings are significant in fewer than 2% of 
patients with IBS19,122,123. 
Carbohydrate breath test 
         The carbohydrate breath test has been used by gastroenterologists for many years to 
detect lactose malabsorption. The test measures exhaled levels of hydrogen and/or methane  
produced during the metabolism of carbohydrate substrates by intestinal bacteria124. Breath 
testing for lactose intolerance may be useful in patients with typical IBS symptoms and 
suspected lactose maldigestion. It is important, however, to establish that dietary intake of 
lactose is 240 mL of milk (or equivalent) per day before testing for lactose intolerance, 
as Suarez et al125 have shown that patients with documented lactose malabsorption are able to 
tolerate 240 mL of milk per day with minimal or no symptoms. Despite the frequent  
occurrence of lactose intolerance in patients with IBS, no causal relationship has been 
established between lactose intolerance and IBS symptoms. However, given the possibility 
that IBS patients are more sensitive to the clinical consequences of lactose maldigestion,126 
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the ACG IBS Task Force has recommended considering a lactose hydrogen breath test in 
patients whose history and food diary review suggest potential lactose maldigestion19. 
Recently, carbohydrate breath test has been used in an attempt to identify patients with small 
intestinal bacterial overgrowth (SIBO)124. Emerging evidence suggests that SIBO plays a 
pathogenic role in IBS,127,128 although this remains contentious. The use of carbohydrate 
breath test to diagnose SIBO in IBS patients has yielded conflicting results. The ACG IBS 
Task Force does not recommend breath testing for SIBO in patients with IBS.19 
Imaging 
               Neither abdominal nor colonic imaging tests are likely to reveal the structural 
abnormalities that explain symptoms of IBS in patients with no alarm features.19,101 
 
Endoscopy or colonoscopy 
                          Studies evaluating endoscopic investigation for suspected IBS do not support 
their routine use in patients without alarm features. Patients younger than 50 years with IBS 
symptoms but no alarm features do not require routine colonic imaging. However, patients 
aged > 50 years should follow expert recommendations for colonic imaging for colorectal 
cancer screening19,129,130 and those aged > 50 years with alarm features should undergo 
colonoscopy to rule out organic disease.19 Patients with IBS-D and alarm features should be 
examined specifically for colorectal cancer and IBD and potentially undergo random mucosal 
biopsies to rule out microscopic colitis, which has a prevalence of 2.3% among patients with 
IBS-D.19,131. The prevalence of microscopic colitis is highly age-dependent as shown in a 
Swedish epidemiology study of 1,018 patients presenting with nonbloody diarrhea who 
underwent colonoscopy; 10% overall, but 20% of those >70 years, received a diagnosis of 
microscopic colitis.132 Patients with IBS-C should be evaluated for mechanical obstruction, 
which can be done by colonoscopy, virtual colonography, or barium enema. Upper 
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endoscopy with small bowel biopsies can be considered to test for celiac disease or SIBO in 
patients with laboratory or stool findings suggestive of malabsorption.19 
Examination of stool forms 
                        Pimentel et al 118 evaluated the variations in frequency and consistency of 
bowel habits over time to distinguish diarrhea secondary to IBS from diarrhea associated with 
active celiac disease, ulcerative colitis (UC), and Crohn’s disease. The basis for this testing is 
that patients  with IBS-D, whose bowel function varies with changes in neuromuscular 
function, will more likely experience irregular bowel function and stool form than those with 
non-IBS causes of diarrhea. Sixty-two IBS-D patients and 37 non-IBS patients (UC, Crohn’s 
disease, celiac disease) completed a questionnaire on their bowel habits and stool forms 
during the preceding week. More IBS than non-IBS patients reported daily variations in stool 
form and frequency of bowel habits.118 Further, 81% of IBS patients and 41% of those 
without IBS reported having at least three stool forms per week; the difference of three stool 
forms per week has a sensitivity of 68% and specificity of 84% in differentiating IBS.118 The 
success of this simple tool in distinguishing between IBS and non-IBS diarrheal disease may 
help avoid unnecessary diagnostic testing.118 
Fecal markers 
                                 Increasing evidence supports the utility of fecal calprotectin and 
lactoferrin in differentiating between IBD and IBS because these markers can identify active 
intestinal inflammation in IBD96,121,133-135.Easily measured in feces, calprotectin and 
lactoferrin are stable, neutrophil-derived proteins that increase in concentration in response to 
leukocyte migration into the gut121,134,136.Although the elevated levels of fecal calprotectin 
and lactoferrin are potentially valuable when screening for intestinal inflammation and 
discriminating between organic and functional diseases119,121 either the cause of the 
inflammatory process leading to the elevations can be discerned with these markers nor are 
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the elevations able to “rule in” a diagnosis of IBS, given that differences between IBS and 
healthy controls are not significant. 
Serologic markers 
                       A number of altered physiological pathways have been identified in patients 
with IBS. The major pathogenic processes include altered gut motility and visceral 
hypersensitivity, which are believed to be due to the dysregulation of brain–gut axis 
pathways,137 immune dysregulation in theGI tract,138 altered gut flora19,127,139,140 and complex 
interactions between neuronal and hormonal factors141. These alterations have prompted 
investigations of IBS biomarkers that may help elucidate the pathophysiology of the disorder 
138 and aid in the diagnosis of the disease141. Lembo et al141 described a panel of 10 serum 
biomarkers that may be useful to help differentiate IBS from non-IBS disease and healthy 
controls.The panel includes interleukin-1β, growth-related oncogene-α, brain-derived 
neurotrophic factor, antihuman anti-tTG, tumor necrosis factor-like weak inducer of 
apoptosis, tissue inhibitor of metalloproteinase-1, neutrophil gelatinase-associated lipocalin, 
antibody to bacterial flagellin (anti-CBir1), anti-Saccharomyces cerevisiae antibody (ASCA-
IgA), and antineutrophil cytoplasmic antibody (ANCA).33 Six of these biomarkers have been 
associated with metabolic dysregulation in IBS, whereas others (ASCA, ANCA, and anti-
CBir1) have typically been associated with IBD. Notably, one study demonstrated elevated 
levels of anti-CBir1 in a subset of patients with postinfectious IBS, presumably the result of 
bacterial infection and immune system activation142.The role of inflammatory processes in 
IBS and concomitant changes in biomarker expression need to be more fully evaluated, 
especially as they relate to potential changes over the course of the disease. Likewise, anti-
tTG is a serum antibody known to be highly specific for only celiac disease. After the 
biomarkers were identified, a predictive modelling tool was used to discern patterns of serum 
concentrations that best differentiated IBS patients from those with non-IBS GI disease (IBD, 
39 
non-IBS functional GI disorders, and celiac disease) and healthy controls, leading 
investigators to conclude that a positive test result can help confirm a suspicion of IBS 
although the sensitivity is insufficient for a negative test to reliably exclude the diagnosis141.  
Prostaglandins :                                                                     
              Prostaglandins (PG) are synthesized by the sequential action of phosholipases, 
cyclooxygenases (COX)-1 and COX-2 , and specific terminal synthases, and exert their 
diverse biological effects through several membrane receptors (Figure5) .                                                                        
In particular, PGE2 is involved in many normal and pathological pathways that are mediated 
by four different E prostanoid receptors (EP1–4). Prostanoids mediate a variety of cellular 
interactions in physiological and pathological processes, including hemostasis and 
thrombosis; glomerular filtration and water balance; ovulation, embryo implantation, and 
development; initiation of labor or abortion; and inflammation and modulation of immune 
responses. Prostanoids are biologically active metabolites of arachidonic acid (AA). In 
response to different stimuli (i.e., physical, chemical, hormonal, cytokines, etc.), AA is 
mobilized from membrane phospholipids through the action of phospholipases (PL) and is 
then converted to prostaglandin (PG)H2 by cyclooxygenase (COX)-1 or COX-2 . COX 
isozymes catalyze a two-step reaction, first cyclizing AA to form PGG2 and then reducing the 
15-hydroperoxy group to form PGH2. Cell-specific isomerases or reductases catalyze the 
conversion of PGH2 to biologically active end-products including PGE2, PGF2α , PGD2, PGI2 
and thromboxane (TX) A2, known collectively as prostanoids . Prostanoids are produced as 
needed in the cell of origin, act primarily as autacoids on the parent cell and/or neighboring 
cells, and have very short half-lives.  COX-1 and COX-2 isozymes catalyze the same 
reactions, show approximately 60% identity in their amino-acid sequence within a given 
species, but are encoded by two different genes, located in different chromosomes. They 















prostanoids serve a number of physiologic “housekeeping” functions, such as modulation of 
platelet aggregation and cytoprotection in the gastrointestinal mucosa.143 In addition, the 
expression of COX-1 is developmentally regulated in many different tissues including 
thymus143, 145, and small changes in expression (e.g., 2- to 4-fold increase) can occur after 
stimulation with hormones or growth factors 143 In contrast, COX-2 is induced in 
macrophages, fibroblasts, vascular endothelial cells, and smooth muscle cells by various 
cytokines, endotoxins, growth factors, or tumor promoters.144 Therefore, COX-2-dependent 
PGs play a major role in inflammation and cell proliferation. The protein expression of 
specific down-stream PG synthases, such as the PGE2 synthases (PGES), could be induced, 
leading to an overall increase in enzymatic activity PGE2 production.145,146 Two isoforms of 
PGES have been described––one membrane-associated (mPGES) and one cytosolic 
(cPGES).145,146 and COX-1 and COX-2 exhibit differential “functional” coupling to each 
isoform of the PGES in different cell types, including platelets.145-148 There has been no 
demonstrated physical binding between COX and PGES; rather, it is more likely that 
intracellular colocalization of these enzymes creates a local zone where AA is processed by 
physically close (but not coupled) enzymes. In addition, intracellular distribution of both 
COXs and PGES appears compartmentalized, in that COX-2 and mPGES are mainly 
membrane-associated and localized in the perinuclear envelope.147 Intracellular 
compartmentalization and functional coupling create preferential and selective “routes” for 
AA in response to different biological demands. Indeed, PGE2 and PGI2 appear to be the 
main prostanoids produced by COX-2, whereas COX-1 can generate all of the PGs147,148, 
depending on the availability of other enzymes present. Finally, the complex regulation and 
tissue specificity of prostanoid actions is enriched by a variety of cell receptors which trigger 
different intracellular signalling.149 PG receptors were first characterized pharmacologically 
and classified based on their sensitivity to five primary prostanoids (i.e., PGE2, PGI2, TXA2, 
42 
PGD2 and PGF2α ), and termed EP (for, E type prostanoid receptor), IP, TP, DP, and FP, 
respectively.149 Among prostanoids, PGE2 has the most receptors: four subtypes of EPs have 
been characterized so far: EP1, EP2, EP3, and EP4, defined on the basis of their 
pharmacological profiles.149 EPs are encoded by distinct genes and have divergent amino-
acid sequences, but all bind PGE2 with higher affinity than other prostanoids. Thus, based on 
multiple receptor subtypes, PGE2 can trigger several different intracellular signal transduction 
paths and has diverse final effects, which sometimes seem to be even functionally opposing 
within the same cell or organ.Activation of the EP1 receptor most likely increases 
intracellular Ca2+, through Gq, phospholipase C (PLC)/inositol triphosphate signaling, and 
protein kinase C (PKC) activity. EP1-mediated Ca2+ increases, however, might not be solely 
dependent on Gq activity.149 EP2 and EP4 stimulate adenylate cyclase via Gs, leading to the 
production of adenosine 3′ ,5′-monophosphate (cyclic AMP, cAMP), which then activates the 
cAMP-dependent protein kinase (PKA).150 Stimulation of EP4 is also known to activate 
phosphoinositide 3′-kinase (PI3K).150 At variance with other EPs, the EP3 has multiple splice 
variants, each having a unique C–terminal cytoplasmic tail 149, which adds more complexity 
to EP3-mediated signaling. EP3 generally inhibits adenylate cyclase through the activation of 
Gi (a pertussis toxin-sensitive G protein); however, EP3 is likely to signal through G-protein–
Rho interactions as well.149.The complexity of the final response to PGE2 is further 
complicated by evidence that multiple EPs are often coexpressed or induced in the same cell 
or organ. The physiological effects of prostaglandins are mediated in part by G-protein-
coupled prostanoid receptors, a family of rhodopsin-like seven transmembrane spanning 
receptors (GPCRs). Activation of a given prostaglandin receptor by its cognate ligand may 
elicit varying responses in different cell types and tissues. Moreover the existence of multiple 
receptors coupling to different signal transduction pathways for a given prostaglandin (e.g., 
EP1–4 for PGE2 and DP/CRTH2 for PGD2) allows for potential synergism or antagonism 
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between prostanoid receptor. Given their structural similarities, that prostaglandins may 
activate more than one subtype of prostaglandin receptor. Complexity is also observed in 
modulation of the immune response by PGE2, whereby activation of specific EP receptors 
has been shown to regulate the function of many cell types including macrophages, dendritic 
cells, T and B lymphocytes leading to both pro- and anti-inflammatory effects.  
PTGS2 (COX-2)  gene 
PTGS2 gene  is mapped to  chromosome 1q25.2-q25(Figure 6) . 
Homo sapiens PTGS2 gene for prostaglandin endoperoxide synthase-2, complete cds 
 
LOCUS       HUMPTGS2               10997 bp    DNA   
       1 attattaaat tatcaaaaag aaaatgatcc acgctcttag ttgaaatttc atgtaagatt 
       61 ccatgcaata aataggagtg ccataaatgg aatgatgaaa tatgactaga ggaggagaaa 
      121 ggcttcctag atgagatgga attttagtca tccgtgtctc atgaagaatc agatgtgtac 
      181 actaagcaaa acagttaaaa aaaaaacctc caagtgagtc tcttatttat ttttttctta 
      241 taagacttct acaaattgag gtacctggtg tagttttatt tcaggtttta tgctgtcatt 
      301 ttcctgtaat gctaaggact taggacataa ctgaattttc tattttccac ttcttttctg 
      361 gtgtgtgtgt atatatatat gtatatatac acacacacat atacatatat atatttttta 
      421 gtatctcacc ctcacatgct cctccctgag cactacccat gatagatgtt aaacaaaagc 
      481 aaagatgaaa ttccagctgt caaaatctcc cttccatcta attaattcct catccaacta 
      541 tgttccaaaa cgagaataga aaattagccc caataagccc aggcaactga aaagtaaatg 
      601 ctatgttgta ctttgatcca tggtcacaac tcataatctt ggaaaagtgg acagaaaaga 
      661 caaaagagtg aactttaaaa ctcgaattta ttttaccagt atctcctatg aagggctagt 
      721 aaccaaaata atccacgcat cagggagaga aatgccttaa ggcatacgtt ttggacattt 
      781 agcgtccctg caaattctgg ccatcgccgc ttcctttgtc catcagaagg caggaaactt 
      841 tatattggtg acccgtggag ctcacattaa ctatttacag ggtaactgct taggaccagt 
      901 attatgagga gaatttacct ttcccgcctc tctttccaag aaacaaggag ggggtgaagg 
      961 tacggagaac agtatttctt ctgttgaaag caacttagct acaaagataa attacagcta 
     1021 tgtacactga aggtagctat ttcattccac aaaataagag ttttttaaaa agctatgtat 
     1081 gtatgtgctg catatagagc agatatacag cctattaagc gtcgtcacta aaacataaaa 
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     1141 catgtcagcc tttcttaacc ttactcgccc cagtctgtcc cgacgtgact tcctcgaccc 
     1201 tctaaagacg tacagaccag acacggcggc ggcggcggga gaggggattc cctgcgcccc 
     1261 cggacctcag ggccgctcag attcctggag aggaagccaa gtgtccttct gccctccccc 
     1321 ggtatcccat ccaaggcgat cagtccagaa ctggctctcg gaagcgctcg ggcaaagact 
     1381 gcgaagaaga aaagacatct ggcggaaacc tgtgcgcctg gggcggtgga actcggggag 
     1441 gagagggagg gatcagacag gagagtgggg actaccccct ctgctcccaa attggggcag 
     1501 cttcctgggt ttccgatttt ctcatttccg tgggtaaaaa accctgcccc caccgggctt 
     1561 acgcaatttt tttaagggga gaggagggaa aaatttgtgg ggggtacgaa aaggcggaaa 
     1621 gaaacagtca tttcgtcaca tgggcttggt tttcagtctt ataaaaagga aggttctctc 
     1681 ggttagcgac caattgtcat acgacttgca gtgagcgtca ggagcacgtc caggaactcc 
     1741 tcagcagcgc ctccttcagc tccacagcca gacgccctca gacagcaaag cctacccccg 
     1801 cgccgcgccc tgcccgccgc tgcgatgctc gcccgcgccc tgctgctgtg cgcggtcctg 
     1861 gcgctcagcc atacaggtga gtacctggcg ccgcgcaccg gggactccgg ttccacgcac 
     1921 ccgggcagag tttccgctct gacctcctgg gtctatccca gtactccgac ttctctccga 
     1981 atagagaagc tacgtgactt gggaaagagc ttggaccgct agagtccgaa agaactccgt 
     2041 ggatattcca gctttcccac aagcactgat cattatgagc cagttactta accgatctga 
     2101 gacactctca cctcctaaat agggatagat gatactaatt tgcaggttgt cattatgata 
     2161 agacaggatc tgatcaatat atgtgaattg tttatatttg gaaccttttt attgagtgga 
     2221 agaagttgtt ttaaatattc tagtcagttc tttcctgctc ccaggaaagc ccggattatg 
     2281 ttttaagata agcaaaatgt cttaaaagta agctgtttta ctttgaattt ttccctaaat 
     2341 gttgattagt gtactagatc cattttaatt tggaaagtga agtgctactt atttgaactt 
     2401 cttaaaaatg ctaattttaa catctaaaga gttaactaag aaaagcttag taacatgatg 
     2461 taccaagttg aatatgctgt tatccttatt tagaatagaa aattggtatt tctacgtttt 
     2521 atccattcta aggcaggtta aaaaattgta tttccatgac tacctatata tttcttgaat 
     2581 ttattattgt aaagttgatt catagtcaaa caattaaatg tttaaattaa gattaagaca 
     2641 ctagagaatg atttatttgc tgtcctttaa ttgcagcaaa tccttgctgt tcccacccat 
     2701 gtcaaaaccg aggtgtatgt atgagtgtgg gatttgacca gtataagtgc gattgtaccc 
     2761 ggacaggatt ctatggagaa aactgctcaa cacgtaagtt tgtcctttgg ttgcctcatt 
     2821 aggagtgggg ctggatacag ttatcattgt atagatttgt gtcttataat gagtcccatt 
     2881 aatttctccc tccctttctt cgtcttcttg cagcggaatt tttgacaaga ataaaattat 
     2941 ttctgaaacc cactccaaac acagtgcact acatacttac ccacttcaag ggattttgga 
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     3001 acgttgtgaa taacattccc ttccttcgaa atgcaattat gagttatgtg ttgacatgta 
     3061 agtacaagtg tctttctaag gtttttagcc ttctcaaaga aaaatatgct ttataatact 
     3121 gtaagcctaa tctaaaaaca tatttccaag cttatcaaaa agactttaag atagctttta 
     3181 agtttgcctt ccatcttaat cgccaaaaat attgacattt agtcccatcc agtttataca 
     3241 gtctgctcac aactctgtat acctcttcta acctttactg tttggtcagt ttgtggaggt 
     3301 agcatggtcc agctgtttat tgaatgccca tgggccacag aattgttctg aacatgtagc 
     3361 acccattaaa ataaatttgg atttggatca gcaagaaaat aactttccat gattctaaag 
     3421 tgggtgccat actcagccat tcctttcata ggcctcttgg atagtgagca gatggctacc 
     3481 tgaaaaatca atattgccag attataatgt gcagagtata tgtattttat taaagatgta 
     3541 tttcaagtgg ccattagact ataaagtgta gttgtttaaa aatagatttt ttttattttg 
     3601 gagttacatt caacctcagg tgccactttc cacattttac aataaaaata atggttgatt 
     3661 tacttaacaa atgagaataa ataaaacatt tttttctttg aaaatttcag ccagatcaca 
     3721 tttgattgac agtccaccaa cttacaatgc tgactatggc tacaaaagct gggaagcctt 
     3781 ctctaacctc tcctattata ctagagccct tcctcctgtg cctgatgatt gcccgactcc 
     3841 cttgggtgtc aaaggtgagt aagaagaatc cattagagat gtattaacta taagacgggc 
     3901 tgcattgctg ccaaaaaaaa aaattgacct tagactacca tttatttatt aacaaaagca 
     3961 gtttttactt ttagcatggt tatctatggg tattttttaa agtatgagtc tatataaact 
     4021 attatgtaaa agcaaatgag cgtcttggta taatgtctta atattttcaa attatttctt 
     4081 tagaaatgaa ataattctaa ttaaaataga taaaatcatt cagtaagaag ttgttccacc 
     4141 atatcttaga actgttgttt atattatgat cctattcaca attgtaattc tcatataaat 
     4201 gaagaattca tgtcctttcc agggaaatgg ttgaagctgg aaaccatcat tttcagcaaa 
     4261 ctaacacagg aacagaaaac caaacgctgc atattctcac tcataagtgg gagttgaaca 
     4321 atgagaccac acggacacag ggaggggaac atcatacact ggggcttgtc gaagggtggg 
     4381 gggctagggg agggatagca ttaagagaaa tacctaacgt agatgacaag ttgatgggtg 
     4441 cagcaaacca ccatggcgca tgtatacggt atcgataagc ttgatatcga attcttggta 
     4501 gattgacagt caccatctcc tttcttgaat acatagatgg attcttacct tagctttctc 
     4561 atttttcagg taaaaagcag cttcctgatt caaatgagat tgtggaaaaa ttgcttctaa 
     4621 gaagaaagtt catccctgat ccccagggct caaacatgat gtttgcattc tttgcccagc 
     4681 acttcacgca tcagtttttc aagacagatc ataagcgagg gccagctttc accaacgggc 
     4741 tgggccatgg ggtaagatag agttaatatc ttagagttag taaaattata ccaaatcata 
     4801 gtcaagggct aacattaaag gagatataca gatagataga tccaaataac ttatccactt 
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     4861 tttttaaaaa gaagtcttat ctataaaaac cttaaaggaa ttttccattt acttcactgg 
     4921 tctagtaaaa ttatacacac acacagacat gcacacacat atataaacat tcacacacat 
     4981 acatatgtac aggtattgtt atttgtaatt tgacccttgt attttttagt ttaaaatgtt 
     5041 agtactgcaa aatgttatgt cctcaaaaac acattgtacc atgattatgc cgctttcaat 
     5101 attgtaaagt gaggtttttg ccgcattatt attttttgga tttcaatagc atagcttcaa 
     5161 gttattcgta agaatttttt ataaataata catttttata cttttttata attaccatat 
     5221 catcatagtg aagtatataa tatatatgat ataagctcaa tatagtatat taattccgtt 
     5281 aaacacaaag acatatcagt ttgtagcttt ggtggataaa caaattaatt tagcaattca 
     5341 tggctatgaa aaatgtatat tttatttaaa aattttaaag aaagctaaat gatcaaatta 
     5401 tttaatgatg aattatatga tagacacttt atataagaaa aacttcaaca gcaacaaatt 
     5461 aaaatttttt catcattttc taggtggact taaatcatat ttacggtgaa actctggcta 
     5521 gacagcgtaa actgcgcctt ttcaaggatg gaaaaatgaa atatcaggta tgcttccttt 
     5581 gactattaag acttagttat taccgcttat acccatattt taaaatccct aaaaatgtgt 
     5641 tccttaactt tttaactgat gtttatttat ttatttattt ttttagataa ttgatggaga 
     5701 gatgtatcct cccacagtca aagatactca ggcagagatg atctaccctc ctcaagtccc 
     5761 tgagcatcta cggtttgctg tggggcagga ggtctttggt ctggtgcctg gtctgatgat 
     5821 gtatgccaca atctggctgc gggaacacaa cagagtatgc gatgtgctta aacaggagca 
     5881 tcctgaatgg ggtgatgagc agttgttcca gacaagcagg ctaatactga taggtaaaca 
     5941 agaaaatgat ttatataaaa ccctcttccc cagggaaaat tagtgtgcta tctttgttat 
     6001 gttttgagta atgacaagat gtggtaaatg aaaactcaca cattctatat acattaaata 
     6061 tgtaagcatg actgataaaa tagctatctt ttgatactga caaggaagaa aacagaaatg 
     6121 aaggaatagc aaattttaaa aattgcattc cagttgcttg aaagcttgtg atcagatgca 
     6181 ataaatgttt ttattattta ttttgtgcaa ataggagaga ctattaagat tgtgattgaa 
     6241 gattatgtgc aacacttgag tggctatcac ttcaaactga aatttgaccc agaactactt 
     6301 ttcaacaaac aattccagta ccaaaatcgt attgctgctg aatttaacac cctctatcac 
     6361 tggcatcccc ttctgcctga cacctttcaa attcatgacc agaaatacaa ctatcaacag 
     6421 tttatctaca acaactctat attgctggaa catggaatta cccagtttgt tgaatcattc 
     6481 accaggcaaa ttgctggcag ggtaagcatt attattgaaa accaaaacaa aagactagtc 
     6541 agtaacttta gaatttctgc cacggaaatt atttttctta aacttactaa aagagtagtt 
     6601 agttatattg ctagtaaaat tattttattg atataagaag cctaactttg tttgaaaagt 
     6661 ctaaactttt agtctagtct acagttgtca gacaaatagc aaattgtacc cctaccttaa 
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     6721 aaatattttc aaaaagtatc tataatctta taggaataaa tattttaggc ttgaatacta 
     6781 gtgttatttt tgaaatgtaa aaaggcaaat tagttctagg ctggtgtccc attgaatttt 
     6841 aagcagagct cctgttgaaa tgtaggtaag catctttcca gcaaataaaa attgtctccg 
     6901 ctgggagttt cagttttacc tgatttgtac ctaaggcaag ctgaatacaa acagtaaata 
     6961 tgcctaaaat tctggtttta caactaattt tactttccac aggttgctgg tggtaggaat 
     7021 gttccacccg cagtacagaa agtatcacag gcttccattg accagagcag gcagatgaaa 
     7081 taccagtctt ttaatgagta ccgcaaacgc tttatgctga agccctatga atcatttgaa 
     7141 gaacttacag gtaagaaaca gtttctaaac ttcttcgttt tttgtttgtt tgtttgtttt 
     7201 tgttgttttt ggttttcttt tcgagatgga gccgccctct gtcacccagg ctggagtgca 
     7261 gtggcgccat ctcggctcac tgcaacctcc gcctcctggg ttcaagcaat tctcctgcct 
     7321 caacttcctg agtagctggg actacaggct cacgtcgcac gcatggataa ttttttgtat 
     7381 tttcagtata gacggggttt caccgtgtta gccaggctgg tctcaaactc ctgacctagt 
     7441 gatccgccgg cttcggcctc ccgaagtgct gggattacag gcgtgagcca ccgcgcctgg 
     7501 cccctaaact tcttaaaaga atcaggggtc aaatggaaac agagaagttg gcagcaaatt 
     7561 gagcaaaaga atcaaactgt tttttatttt gtgaagtttg acattggttg tatctctgtc 
     7621 ttcatcgcct tcacaggaga aaaggaaatg tctgcagagt tggaagcact ctatggtgac 
     7681 atcgatgctg tggagctgta tcctgccctt ctggtagaaa agcctcggcc agatgccatc 
     7741 tttggtgaaa ccatggtaga agttggagca ccattctcct tgaaaggact tatgggtaat 
     7801 gttatatgtt ctcctgccta ctggaagcca agcacttttg gtggagaagt gggttttcaa 
     7861 atcatcaaca ctgcctcaat tcagtctctc atctgcaata acgtgaaggg ctgtcccttt 
     7921 acttcattca gtgttccaga tccagagctc attaaaacag tcaccatcaa tgcaagttct 
     7981 tcccgctccg gactagatga tatcaatccc acagtactac taaaagaacg ttcgactgaa 
     8041 ctgtagaagt ctaatgatca tatttattta tttatatgaa ccatgtctat taatttaatt 
     8101 atttaataat atttatatta aactccttat gttacttaac atcttctgta acagaagtca 
     8161 gtactcctgt tgcggagaaa ggagtcatac ttgtgaagac ttttatgtca ctactctaaa 
     8221 gattttgctg ttgctgttaa gtttggaaaa cagtttttat tctgttttat aaaccagaga 
     8281 gaaatgagtt ttgacgtctt tttacttgaa tttcaactta tattataaga acgaaagtaa 
     8341 agatgtttga atacttaaac actgtcacaa gatggcaaaa tgctgaaagt ttttacactg 
     8401 tcgatgtttc caatgcatct tccatgatgc attagaagta actaatgttt gaaattttaa 
     8461 agtacttttg gttatttttc tgtcatcaaa caaaaacagg tatcagtgca ttattaaatg 
     8521 aatatttaaa ttagacatta ccagtaattt catgtctact ttttaaaatc agcaatgaaa 
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     8581 caataatttg aaatttctaa attcataggg tagaatcacc tgtaaaagct tgtttgattt 
     8641 cttaaagtta ttaaacttgt acatatacca aaaagaagct gtcttggatt taaatctgta 
     8701 aaatcagtag aaattttact acaattgctt gttaaaatat tttataagtg atgttccttt 
     8761 ttcaccaaga gtataaacct ttttagtgtg actgttaaaa cttcctttta aatcaaaatg 
     8821 ccaaatttat taaggtggtg gagccactgc agtgttatct taaaataaga atattttgtt 
     8881 gagatattcc agaatttgtt tatatggctg gtaacatgta aaatctatat cagcaaaagg 
     8941 gtctaccttt aaaataagca ataacaaaga agaaaaccaa attattgttc aaatttaggt 
     9001 ttaaactttt gaagcaaact tttttttatc cttgtgcact gcaggcctgg tactcagatt 
     9061 ttgctatgag gttaatgaag taccaagctg tgcttgaata acgatatgtt ttctcagatt 
     9121 tcctgttgta cagtttaatt tagcagtcca tatcacattg caaaagtagc aatgacctca 
     9181 taaaatacct cttcaaaatg cttaaattca tttcacacat taattttatc tcagtcttga 
     9241 agccaattca gtaggtgcat tggaatcaag cctggctacc tgcatgctgt tccttttctt 
     9301 ttcttctttt agccattttg ctaagagaca cagtcttctc agctacttcg tttctcctat 
     9361 tttgttttac tagttttaag atcagagttc actttctttg gactctgcct atattttctt 
     9421 acctgaactt ttgcaagttt tcaggtaaac ctcagctcag gactgctatt tagctcctct 
     9481 taagaagatt aaaagagaaa aaaaaaggcc cttttaaaaa tagtatacac ttattttaag 
     9541 tgaaaagcag agaattttat ttatagctaa ttttagctat ctgtaaccaa gatggatgca 
     9601 aagaggctag tgcctcagag agaactgtac ggggtttgtg actggaaaaa gttacgttcc 
     9661 cattctaatt aatgcccttt cttatttaaa aacaaaacca aatgatatct aagtagttct 
     9721 cagcaataat aataatgacg ataatacttc ttttccacat ctcattgtca ctgacattta 
     9781 atggtactgt atattactta atttattgaa gattattatt tatgtcttat taggacacta 
     9841 tggttataaa ctgtgtttaa gcctacaatc attgattttt ttttgttatg tcacaatcag 
     9901 tatattttct ttggggttac ctctctgaat attatgtaaa caatccaaag aaatgattgt 
     9961 attaagattt gtgaataaat ttttagaaat ctgattggca tattgagata tttaaggttg 
    10021 aatgtttgtc cttaggatag gcctatgtgc tagcccacaa agaatattgt ctcattagcc 
    10081 tgaatgtgcc ataagactga ccttttaaaa tgttttgagg gatctgtgga tgcttcgtta 
    10141 atttgttcag ccacaattta ttgagaaaat attctgtgtc aagcactgtg ggttttaata 
    10201 tttttaaatc aaacgctgat tacagataat agtatttata taaataattg aaaaaaattt 
    10261 tcttttggga agagggagaa aatgaaataa atatcattaa agataactca ggagaatctt 
    10321 ctttacaatt ttacgtttag aatgtttaag gttaagaaag aaatagtcaa tatgcttgta 
    10381 taaaacactg ttcactgttt tttttaaaaa aaaaacttga tttgttatta acattgatct 
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    10441 gctgacaaaa cctgggaatt tgggttgtgt atgcgaatgt ttcagtgcct cagacaaatg 
    10501 tgtatttaac ttatgtaaaa gataagtctg gaaataaatg tctgtttatt tttgtactat 
    10561 ttaaaaattg acagatcttt tctgaagata aactttgatt gtttctatac atctttgtca 
    10621 tatgacataa gatttctctg aagcattact cttaaaccat tatcttgcat tctcctacct 
    10681 attcaaaact aggactggcc cttcatgaaa tggttttgcc ctcaattata tagaggcttc 
    10741 ctagagtcac tatttaaatc tcataatcct tattcactgc gacactgtgt tggaaaatgt 
    10801 ctagtttgtg tatctttaca gaagatggca aacaagctta ttttcattgc ctagtctaga 
    10861 agaagaagaa aaaaatacac aataaggcaa agaataagac atatattatg aagggggcac 
    10921 aaagttaaga agttcaaaga ggaggaaatt atacaaagtt gggcaaatca ttgatgcaaa 
    10981 agctcatagg cttttgt 
 
COX-2 enzyme                                                            
Catalytic activity:        Arachidonate + AH(2) + 2 O(2) = prostaglandin H(2) + A + H(2)O 
                                        The first rate-limiting step in the conversion of arachidonic acid to 
prostaglandins is catalyzed by PTGS. The cyclooxygenases oxygenate arachidonic acid (AA) 
in the committed step of prostaglandin biogenesis. Substitutions of I434V, H513R, and 
I523V constitute the only differences in residues lining the cyclooxygenase channel between 
COX-1 and COX-2. These changes create a hydrophobic pocket in COX-2, with Arg-513 
located at the base of the pocket, which has been exploited in the design of COX-2-selective 
inhibitors. Tazawa et al. (1994) isolated the entire PGHS2 gene and its 5-prime flanking 
region and showed that it contains 10 exons and spans 7.5 kb.  PTGS2 is a protein that is 
expressed as part of the acute response to inflammation151 and is the main enzyme 
responsible for transforming arachidonic acid into prostaglandins. Expression of PTGS2 is 
tightly controlled, with basal levels low to nonexistent in most tissue types. In addition, 
PTGS2 mRNA has a very short half-life regulated by sequence-specific elements in the 3' 












Figure  7 
 
 











known common polymorphisms;  The SNPs are located at base pairs 926; 3,050; 5,209; 
8,473; and 9,850 . 
                                            COX-2 exists as a homodimer, each monomer with a molecular 
mass of about 70 kDa. The tertiary and quaternary structures of COX-1 and COX-2 enzymes 
are almost identical. Each subunit has three different structural domains: a short N-terminal 
epidermal growth factor (EGF) domain; an α-helical membrane-binding moiety; and a C-
terminal catalytic domain.  COX enzymes are monotopic membrane proteins; the membrane-
binding domain consists of a series of amphipathic α helices with several hydrophobic amino 
acids exposed to a membrane monolayer. COX-1 and COX-2 are bifunctional enzymes that 
carry out two consecutive chemical reactions in spatially distinct but mechanistically coupled 
active sites. Both the cyclooxygenase and the peroxidase active sites are located in the 
catalytic domain, which accounts for approximately 80% of the protein. The catalytic domain 
is homologous to mammalian peroxidases such as myeloperoxidase154,155 
                            Different ligands bind either the allosteric or the catalytic subunit ( Figure 
8) . Allosteric subunit binds a non-substrate, activating FA (e.g., palmitic acid). The allosteric 
subunit with bound fatty acid activates the catalytic subunit by decreasing the Km for AA.[5] 
COX-2 exists as a homodimer, each monomer with a molecular mass of about 70 kDa.It has 
been found that human PGHS-2 functions as a conformational heterodimer having a catalytic 
monomer (E-cat) and an allosteric monomer (E-allo). Heme binds only to the peroxidase site 
of E-cat while substrates, as well as certain inhibitors, bind the COX site of E-cat. E-cat is 
regulated by E-allo in a way dependent on what ligand is bound to E-allo. Substrate and non-
substrate fatty acid (FAs) and some COX inhibitors preferentially bind to the COX site of E-
allo. AA can bind to E-cat and E-allo, but the affinity of AA for E-allo is 25 times that for 
Ecat. Palmitic acid, an efficacious stimulator of huPGHS-2, binds only E-allo in palmitic 

















inhibitors depending on the fatty acid and whether the inhibitor binds E-cat or E-allo. Studies 
suggest that the concentration and composition of the free fatty acid pool in the environment 
in which PGHS-2 functions in cells, also referred to as the FA tone, is a key factor regulating 
the activity of PGHS-2 and its response to COX inhibitors.156   COX enzymes produce PGH2 
from AA in two consecutive chemical reactions157. PGH2 is converted to other prostanoids 
by tissue-specific enzymes called isomerases. In the first step of the reaction, two moles of 
oxygen are added to arachidonic acid to yield PGG2. This is referred to as the COX reaction. 
The latter is followed by the peroxidase reaction, which reduces PGG2 to give PGH2 (Figure 
9). The COX reaction and the peroxidase reaction occur at two different locations in COX 
enzymes. Both the peroxidase and the cyclooxygenase activities are inactivated during 
catalysis by mechanism-based, first-order processes, which means that PGHS-2 peroxidase or 
cyclooxygenase activities fall to zero within 1–2 minutes, even in the presence of sufficient 
substrates.158-160        
Mechanism 
The conversion of arachidonic acid to PGG2 can be shown as a series of radical reactions 
analogous to polyunsaturated fatty acid autoxidation (Figure 10.)161 A hydroperoxide 
oxidizes the heme to a ferryl-oxo derivative that either is reduced in the first step of the 
peroxidase cycle or oxidizes Tyrosine 385 to a tyrosyl radical. The tyrosyl radical can then 
oxidize the 13-pro(S) hydrogen of arachidonic acid to initiate the COX cycle.The 13-pro(S) -
hydrogen is abstracted and dioxygen traps the pentadienyl radical at carbon 11. The 11-
peroxyl radical cyclizes at carbon 9 and the carbon-centered radical generated at C-8 cyclizes 
at carbon 12, generating the endoperoxide. The allylic radical generated is trapped by 
dioxygen at carbon 15 to form the 15-(S) -peroxyl radical; this radical is then reduced to 
PGG2 . This is supported by the following evidence: 1) a significant kinetic isotope effect is 








trapped during catalysis 162 3) small amounts of oxidation products are formed due to the 
oxygen trapping of an allylic radical intermediate at positions 13 and 15.163,164 Another 
mechanism is the 13-pro (S )-hydrogen is deprotonated and the carbanion is oxidized to a 
radical is theoretically possible. However, oxygenation of 10,10-difluoroarachidonic acid to 
11-(S )-hydroxyeicosa-5,8,12,14-tetraenoic acid is not consistent with the generation of a 
carbanion intermediate because it would eliminate fluoride to form a conjugated diene.165[15] 
The absence of endoperoxide-containing products derived from 10,10-difluoroarachidonic 
acid has been thought to indicate the importance of a C-10 carbocation in PGG2 synthesis166 
However, the cationic mechanism requires that endoperoxide formation comes before the 
removal of the 13-pro (S )-hydrogen. This is not consistent with the results of the isotope 
experiments of arachidonic acid oxygenation.167 
                                        In genotype association studies, the relationship between genotype 
and clinical phenotype includes “black box” intermediaries such as the effect of the 
environment and other unknown biological factors( Figure 11). Lower panel: In genotype-
endophenotype association studies, the relationship between candidate genes that affect the 
biomarkers (endophenotype) of interest is explored with confidence that the biomarkers are 
associated with a known (often robust) relationship with the main manifestations of the 
clinical phenotype. Since the biomarker functions are measurable and have a defined 
coefficient of variation, the size of the function that is detectable can be used to inform the 
much smaller sample size for the genetic association study. 
                          By studying the genetic associations between candidate genes and in depth 
physiological functions, it is possible to identify genetic susceptibility or, at least, to generate 
hypotheses that can be tested to evaluate the role of the candidate mechanism. 
                           The single genetic variation most intensely studied in search of an 















the gene SLC6A4 responsible for the synthesis of 5-HT transporter, SERT. The latter is 
central to fine-tuning brain 5HT neurotransmission, and is abundant in cortical and limbic 
areas, and affects emotional aspects of behavior .168 This polymorphism () results in short (s) 
and long (l) allele, based on the presence or absence of a 44 bp insertion. 168,169  The SLC6A4 
gene is located on chromosome 17q11.1–17q12 and organized into 14 exons spanning ~ 38 
kb.169 A study from Mayo Clinic did not demonstrate a significant association of any 5-
HTTLPR allele and IBS; this contrasted with the results of the small study by Pata et al. 
However studies from Western countries and Asia provided contradictory results.170 A meta-
analysis of most of the studies currently in the literature suggests that among Caucasians and 
Asians, odds ratio for IBS in subjects for SS or LS vs LL (odds ratio [OR] 1.0, 95% CI 0.8–
1.2) and for SS vs LL or LS (OR 1.0, 95% CI 0.7–1.4) are not significant.  
          Another genetic variation related to 5-HT control is STin2 VNTR, which is located in 
intron 2. It consists of variable number 168,171,172 identical 17-bp segments173; the 10/12 
genotype has been associated with IBS in one study.174. However, other studies found no 
association between STin2 VNTR and IBS .175-177 
                 A SNP, rs25531, located immediately upstream of 5-HTTLPR is strongly linked, 
yet has opposing effects on SERT expression. The rs25531 G allele lowers SERT 
transcription compared with the A-allele and occurs most frequently with 5-HTTLPR – L.. 
Carriers of the G allele (minor allele frequency 10%) of rs25531 had increased odds [OR 3.3 
(95% CI 1.1–9.6)] of having IBS compared with healthy controls .173 The A:G allele 
frequency (percent) in controls in this study was 96:4, in contrast to the IBS patients (89:11). 
Given the relatively small numbers of patients (186 with IBS) in the study, this result requires 
confirmation, particularly because G allele frequencies of 10% and 18% are reported in two 
studies (that included 20 and 190 patients respectively) conducted in the United States and 
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reported in NCBI178 and these G allele frequencies are closer to the 11% observed in the IBS 
cohort studied in the Northwest region of the United States. 
                In a study of 54 patients with Rome I positive IBS and 107 healthy individuals, 
Pata et al reported that increased risk of IBS in patients with homozygous C allele of the 102 
T/C polymorphisms  or homozygous A allele of the -1438 G/A polymorphism  of the 5-HT2A 
receptor gene. In addition, the T/T genotype of 102 T/C polymorphism may be associated 
with more severe pain in patients with IBS. 179 
              In a collaborative study between centers in England and Germany, investigating the 
potential role of genetic variation in 5-HT3 receptors, an initial study was conducted in 200 
IBS patients and 100 healthy controls from the UK. The novel HTR3E 3′-UTR variant 
c.*76G>A (rs62625044) was associated with female IBS-D. This association was confirmed 
in a replication study, including 119 IBS-D patients and 195 controls from Germany. Using a 
reporter assay, Kapeller et al showed that c.*76G>A affected the binding of microRNA-510 
(miR-510) to the HTR3E 3′-UTR and caused elevated protein expression in 2 different cell 
lines. In addition, HTR3E and miR-510 co-localize in enterocytes as shown by in situ 
hybridization and RT-PCR.180 
α2-Adrenergic Receptors 
             Adrenergic receptor and 5-HTTLPR genotypes were evaluated in an original cohort 
171 consisting of 274 IBS and120 controls.. There was significant association between IBS-C 
and the α2C Del 322–325 deletion, which alters the coding region of the gene. This variation 
results in a receptor that has markedly decreased agonist-mediated responses in vitro.181 
There is also evidence that the same variation results in altered cold pain perception without 
affecting cognition.182 
            There was a non-significant association of IBS-C with the α2A -1291 C>G 
(rs1800544) genotype. These provocative associations demonstrated between genetic 
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           Catechol-O-methyltransferase (COMT), which catalyzes the transfer of a methyl 
group from S-adenosyl methionine to catecholamines (such as dopamine, norepinephrine and 
epinephrine) and their inactivation, is a key regulator of pain perception, cognitive function, 
and affective mood. Three common haplotypes of the human COMT gene, consisting of two 
synonymous and one non-synonymous SNPs, code for differences in COMT enzymatic 
activity due to a reduced amount of translated protein and are associated with pain sensitivity. 
A Valine158Methionine (Val158Met) allele has been identified in the COMT gene associated 
with a three-to-four fold decline of the COMT activity compared with that of the non-
Val158Met allele.183In a recent study, interaction of gender, age, COMT Val158Met 
polymorphism was found in dyspepsia.184 
 
G-proteins 
                       G protein-coupled receptors are present on every excitable cell and every cell 
that is susceptible to regulation in the body.185 It is estimated that 80% of ligand-receptor 
interactions are mediated through G-protein coupled receptors; activation of the receptor 
leads to production of the βγ heterodimer from the heterotrimeric G protein. This is catalyzed 
by GNβ3. Initial studies suggested an association between GNβ3 C825T and dyspepsia185,186 
however, we did not identify an association of IBS with GNβ3 C825T.187 The latter finding 
has been replicated in a smaller study.188 G protein coupled receptors are also important 
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potential sites for drug action. A preliminary report suggests that that the CC genotype, which 
results in decreased intracellular signal transduction, may predict response to therapy in 
patients with functional dyspepsia treated, based on their predominant symptom, with proton 
pump inhibitors, prokinetics, spasmolytics and tricyclic antidepressants. At 12 months’ 
follow up, logistic regression analysis showed that the CC genotype was associated with 
response to therapy. 189 
Mitochondrial DNA  
          Mitochondrial (mt) genome is involved in generation of energy in tissues including the 
brain, nerves and muscles. There are >100 pathogenic point mutations and many 
rearrangements associated with multi-system or tissue-specific diseases 190, including 
conditions rarely seen by gastroenterologists such as mitochondrial neurogastrointestinal 
encephalopathy (which presents with pseudo-obstruction and small bowel diverticulosis) and 
Kearns-Sayre syndrome (which presents with high dysphagia). 
                Since mitochondria are almost exclusively maternally inherited and IBS is more 
commonly encountered in females, it was hypothesized that mtDNA SNPs could confer risk 
to IBS. Most mtDNA SNPs are found in the hyper-variable region of non-coding control 
region “D loop” (including 16519 C>T SNP). The 3010 SNP is located in the 16S ribosomal 
RNA gene. These two SNPs, 16519C>T and 3010G>A, have been associated with migraine 
and cyclic vomiting syndrome 191, which are commonly encountered in patients with IBS. In 
addition, 16519T alone is associated with diabetes and with a poorer prognosis in individuals 
with pancreatic cancer. 
                  Given this background, we explored the association of any FGID (vs health) with 
H haplogroup, defined by the presence of 7028C polymorphism.192 A non-significant lower 
odds for any FGID in haplogroup H (relative to all other haplogroups) was observed (OR 
[95%CI]) = 0.8 [0.6, 1.1]). Constipation-predominant IBS and alternating constipation and 
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diarrhea IBS are less prevalent in individuals with the 7028C mtDNA polymorphism than in 
individuals with 7028T. Among those with 7028C, non-specific abdominal pain (chronic 
abdominal pain or dyspepsia) was significantly associated with 3010A compared with 
3010G. (No significant associations of mtDNA genotypes tested were detected with small 
bowel or colonic transit, rectal compliance, and motor or sensory functions. The relationship 
of mtDNA and manifestations of IBS require further study. 
SCN5A 
            The SCN5A-encoded Nav1.5 Na+ channel is expressed in interstitial cells of Cajal and 
smooth muscle in the circular layer of the human intestine. Mutational analysis was 
performed on genomic DNA in 49 subjects with IBS associated with at least moderately 
severe abdominal pain. One patient had a loss-of-function missense mutation, G298S, that 
was not observed in 1,500 healthy control subjects. Na+ currents were recorded from the four 
common human SCN5A transcripts in transfected HEK-293 cells. The G298S-SCN5A 
missense mutation caused a marked reduction of whole cell Na+ current and loss of function 
of Nav1.5, and the authors suggest SCN5A as a candidate gene in the pathophysiology of 
IBS.193 However, the mutation appears to be rare even among a subset with at least 
moderately severe pain in IBS. 
Cannabinoid Metabolism 
               The endocannabinoid anandamide is produced, metabolized and released from the 
postsynaptic membrane. The released anandamide stimulates the cannabinoid (CB) receptor 
on presynaptic membrane to modulate its function, such as the production of transmitters like 
acetylcholine. The rate limiting enzyme for metabolism of anandamide is fatty acid amyl 
transferase (FAAH). If this enzyme does not work well, there is more anandamide that 
reaches the presynaptic membrane, and greater effect on the transmitter released from the 
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presynaptic neuron. A common SNP in FAAH is FAAH C385A. This SNP is significantly 
associated with D-IBS and with rapid colon transit.194 
SLC6A4 
                       5-HTTLPR genotype (s allele) is associated with higher pain sensory ratings 
during rectal distension studies in health and IBS.195 The higher pain sensation is not the 
result of a decrease in rectal compliance since the same study identified that rectal 
compliance is increased in patients carrying the s allele of 5-HTTLPR.195 The 5-HTTLPR SS 
genotype is also associated with greater regional cerebral blood flow in response to colorectal 
distension in patients with IBS, with regional increases most pronounced in the left anterior 
cingulate cortex, right parahippocampal gyrus and left orbitofrontal cortex, which may 
represent increased activity in the emotional motor system of the brain.196 
 
Neuropeptide S receptor 1 
               Neuropeptide S receptor 1 (NPSR1) gene maps to a region of chromosome 7 and is 
associated with asthma and inflammatory bowel disease.197 NPSR1 is expressed on the 
intestinal epithelium, and is up-regulated in inflammation. It may conceivably be associated 
with IBS given the increasing evidence of association with minor inflammation or prior 
infection with IBS. In a study of 18 NPSR1 polymorphisms198 that span the gene in 699 
participants (~2/3 patients, 1/3 healthy controls), NPSR1_RS1419793 was significantly 
associated with colonic transit .While the mechanisms are unclear, whereby NPSR1 SNPs 
might result in altered motor functions, the data suggest that specific NPSR1 alleles might act 
as genetic risk factors for colonic diseases that are associated with changes in epithelial 
barrier function, including IBD and IBS.          
          The COX2.8473 SNP is located downstream of the stop codon, in the 3’-UTR region. 
Binding of proteins to the 3’-UTR can control mRNA stability and degradation, and this may 
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be affected by polymorphisms.199,200 This region is characterized by multiple repeats of AU-
rich elements, which are also found in several other genes encoding inflammatory mediators 
(cytokines and protooncogenes),whose mRNA is very unstable. It may be possible that the 
T→C substitution at COX2.8473 stabilizes the mRNA of COX2, thus resulting in a larger 















































Mild inflammation is a component in the pathogenesis of  Irritable Bowel Syndrome. 
 COX2 gene polymorphism is associated with increased production of  prostaglandins. 
 Activation of serotonin 5-HT1A receptor in the enteric nervous system suppresses gut 
motility 
 5-HT1A receptor responsiveness is reduced by arachidonic acid metabolite 
                                   As there is increased incidence of bronchial asthma in patients with 
Irritable Bowel Syndrome, the polymorphism associated with  increased production of  
prostaglandin PTGS2.8473T→C SNP  is investigated in this study to  know whether the same 
polymorphism is associated with  patients of  Irritable Bowel Syndrome. 
 






                                              
















MATERIALS AND METHODS 
STUDY POPULATION 
CASES 
                    The study sample comprised 50 unrelated  Irritable Bowel Syndrome patients 
(30male ,20 female ) of Mean age of 40.56 ±  11.36 years. Inclusion criteria was individuals 
aged between 18 and 65 years who satisfied Rome II criteria  for IBS . Organic 
gastrointestinal diseases and clinically significant systemic diseases, individuals with known 
lactose intolerance or immunodeficiency or who had any recent transient illness (i.e. within 2 
weeks or participation in the study) such as viral illnesses or chest infections  were excluded. 
CONTROL SUBJECTS 
Controls were recruited from out patient department during their visit for non gastric illness. 
Age , Sex  were matched.  
METHODS 
2 mL of blood was obtained by Venipuncture & collected in EDTA tub & was centrifuged at 
2000 rpm for twenty minutes to get the buffy coat for DNA extraction  
BUFFY COAT SEPARATION 
      Buffy coat was separated by centrifugation of  EDTA tubes at 2000 revolutions for 20 
minutes. Buffy coat was transferred to 2mL eppendorf and was used for DNA extraction.  
 DNA EXTRACTION BY MODIFIED HIGH SALT METHOD201 
RBC Lysis: 
400µL of buffy coat in a 2mL eppendorf is mixed with 1.6mL of 0.17M ammonium chloride 
and mixed by inversion until red cells are lysed for about 10 minutes 
The cells are centrifuged at 4000rpm for 10minutes. 
The white cell pellet is washed with 800µL of 0.17M ammonium chloride solution. The 
procedure is repeated till a clear white cell pellet is obtained. 
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WBC Lysis 
To the pellet 500 µL of TKM I solution is added. It is centrifuged at 10,000rpm for 
10minutes. 
Nuclear Lysis 
Discard the supernatant. To the pellet add 500 µL of TKM II solution. To that add 300 µL of 
6M  Nacl and 50 µL of 10% SDS. 
Mix well (vortex), Centrifuge at 10,000 rpm for 10 minutes. 
Save the supernatant. Transfer it to 1.5mL eppendorf. 
DNA Precipitation 
To the supernatant double the volume of 100% ethanol is added. 
The sample is stored at -20◦C for 1 hour. 
Then it is centrifuged at 10,000 rpm for 20minutes at 4◦C in a refrigerated centrifuge. 
The supernatant is discarded. To this 500 µL of 70% ethanol is added. The pellet is mixed 
and centrifuged at 10,000 rpm for 10minutes at 4◦C. 
Supernatant is discarded and the pellet is air dried. 
Storage 
To the pellet 30 µL of LTE buffer is added and the extracted DNA is stored at   -20◦C for 
future use.  
Identification 
Extracted DNA was identified by 0.8% agarose gel electrophoresis with a constant voltage of 







       =     0.0203 × 50 × 100 















Reaction buffer consisted of Tris  Hcl  ‐  10mM at  pH 8.3 

















































































Allele frequencies were calculated by allele counting. 
 
Age, Sex, Comorbitity with mental disorders, H/OAsthma, H/OFibromyalgic symptoms, H/O 
Sexual and physical abuse, H/O Major life stress were compared between control subjects 
and patients by students t test. 
 
Genotype frequency distribution between cases and controls were compared with a χ2 test for 









































1  41  M  Y  Y  N N  N  TC 
2  25  M  N  N  N  N  N  TT 
3  29  M  N  N  N  N  N  TT 
4  33  F  Y  Y  N  Y  N  CC 
5  50  F  Y  Y  N  N  N  TC 
6  38  F  N  N  N  N  N  TT 
7  48  M  Y  Y  N  Y  N  CC 
8  45  F  N  N  Y  N  N  TT 
9  33  M  N  Y  N  N  N  TC 
10  50  M  Y  N  N  N  N  TT 
11  53  M  Y  Y  N  N  N  CC 
12  41  F  Y  Y  N  N  N  TC 
13  28  M  Y  N  N  N  N  TT 
14  42  M  N  N  N  N  N  TT 
15  38  F  N  N  N  N  N  TT 
16  40  M  Y  Y  N  Y  N  CC 
17  35  F  Y  Y  Y  N  Y  TC 
18  49  F  N  Y  N  N  N  TT 
19  43  M  Y  N  N  N  N  TC 
20  24  M  Y  Y  N  N  N  TT 
21  47  F  N  Y  N  N  N  TT 
22  28  F  Y  Y  N  N  N  TC 
23  25  M  Y  N  N  Y  N  TC 

















25  47  M  Y  N  N  Y  N  TC 
26  60  F  N  Y  N  N  N  TT 
27  45  M  Y  Y  N  N  N  CC 
28  50  F  Y  N  N  N  N  TC 
29  37  M  Y  Y  Y  Y  N  CC 
30  32  M  N  Y  N  N  N  TT 
31  22  M  Y  N  N  Y  N  TC 
32  60  M  Y  Y  N  N  N  TC 
33  60  F  Y  Y  N  N  N  TC 
34  30  F  Y  N  N  N  N  TT 
35  60  F  N  N  N  N  N  TT 
36  50  F  N  N  N  N  N  TC 
37  38  M  Y  N  N  N  N  TC 
38  28  M  Y  Y  N  Y  N  CC 
39  40  F  N  Y  N  N  N  TC 
40  46  M  Y  Y  N  N  N  TT 
41  29  F  N  N  N  Y  Y  TT 
42  56  M  N  N  N  N  N  TT 
43  40  M  Y  Y  N  N  N  TC 
44  50  F  N  N  N  N  N  TT 
45  20  M  N  N  N  N  N  TT 
46  54  M  N  Y  N  N  N  TC 
47  58  M  Y  N  N  N  N  TT 
48  16  M  Y  N  N  N  N  TT 
49  26  F  N  Y  N  N  N  TT 
50  34  M  N  N  N  Y  N  TT 
AVG  39.84  M:F=30:20 Y=28:N=22  Y=26:N=24  Y=3:N=47  Y=10:N=40 Y=2:N=48   
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MASTER CHART  FOR CONTROLS 
















1  28  M  N  N  N  N  N  TT 
2  48  M  Y  Y  N  N  N  TT 
3  26  M  N  N  N  N  N  TT 
4  34  F  Y  Y  N  Y  N  TT 
5  54  F  N  Y  N  N  N  TT 
6  40  F  Y  Y  N  N  N  TT 
7  46  M  Y  Y  N  N  Y  TC 
8  50  F  Y  Y  N  N  N  TC 
9  30  M  Y  N  N  N  N  TT 
10  56  M  Y  Y  N  N  N  TC 
11  60  M  Y  Y  N  N  N  TT 
12  45  F  N  Y  N  N  N  TT 
13  33  M  N  N  N  N  N  TT 
14  41  M  N N N N  N TT 
15  61  F  Y  Y  Y  N  N  CC 
16  37  M  N N N N  N TT 
17  32  F  N Y N N  N TT 
18  50  F  N Y N N  N TT 
19  40  M  Y Y N N  N TT 
20  28  M  N N N N  N TT 
21  49  F  Y  Y  N  Y  N  CC 
22  29  F  N N N N  N TT 
23  28  M  N N N N  N TT 







25  60  M  Y  Y  N  N  N  TT 
26  47  F  Y  Y  N  Y  N  CC 
27  25  M  N  N  N  N  N  TT 
28  47  F  Y  Y  N  N  N  TC 
29  43  M  Y  Y  N  N  N  TT 
30  35  M  N  N  N  N  N  TT 
31  29  M  N  N  N  N  N  TT 
32  38  M  N  N  N  N  N  TT 
33  60  F  Y Y Y Y N CC 
34  33  F  Y  Y  N  N  N  TC 
35  53  F  Y Y N N  N TT 
36  40  F  Y Y N N  N TC 
37  29  M  Y N N N  N TT 
38  24  M  N N N N  N TT 
39  42  F  Y Y N Y N CC 
40  48  M  Y  Y  N  N  N  TC 
41  16  F  Y N N N  N TC 
42  58  M  Y N N N  N TT 
43  38  M  N  N  N  N  N  TC 
44  28  F  Y  Y  N  Y  N  CC 
45  43  M  Y  Y  N  N  N  TC 
46  50  M  N  Y  N  N  N  TT 
47  52  M  N  Y  N  N  N  TC 
48  38  M  N  N  N  N  N  TC 
49  50  F  N  N  N  N  N  TC 
50  25  M  N  N  N  N  N  TC 
AVG 









































































































































































































































Table 5 shows Age , Sex ,Comorbitity with mental disorders , Fibromyalgia, Asthma, Sexual 
and  physical abuse, Major life stress,  risk factor distribution among patients and control 
subjects. We obtained a nonsignificant p value with respect to all the confounding variables 
like Age , Sex , Comorbitity with  mental disorders , Fibromyalgia, Asthma , Sexual and  
physical abuse, Major life stress.  
Table 6 & 7 shows Genotype distribution and Allele frequencies of COX2  gene in patients 
with IBS and control subjects. The Allele frequencies were TT = 30, TC =14 and CC = 6. 
This was found to be in  Hardy Weinberg equilibrium. χ2 value is 3.84, P value is .37. 
               TT genotype was frequent among cases (60%) when compared to controls (50%).                  
TC genotype was common among controls (36%) when compared to cases (28%).                               
CC genotype was common among cases (14%) when compared to controls (12%).   
There is no difffence in T+ genotype  among controls (88%) &  cases (86 %). P value =.766                      
There was no significant difference in the distribution of CC genotype between cases (14%) 




               
                      
         
 



























Genetic factors in combination with a number of environmental risk factors are involved in  
predisposition to  Irritable Bowel Syndrome.  
                 Recently, interest has focused on the presence of mucosal inflammation in the 
pathogenesis that may be particularly valid for diarrhoea-predominant IBS202        
                      5HT1A  receptor  decreases gut motility .  As the arachidonic acid metabolite 
reduces the responsiveness of the  5HT1A  receptor  system  which may consequently increase 
gut motility, any polymorphism associated with arachidonic acid metabolism is being looked  
for. As studies  showed  increased amount of PGE2  in IBS ,  polymorphism in the  COX 
pathway, if any is being studied. As studies showed   increased prevalence of bronchial 
asthma in  IBS patients, the COX2(8473 T → C)  gene polymorphism, which is associated 
with  bronchial asthma, was analyzed in this study. 
                            In this study, the effect of  polymorphism in the 3-UTR region of the COX2 
gene  (8473 T → C) is assessed in the occurence of  IBS.  
                            CC genotype which is associated with increased amount of PGE2   levels in 
previous studies involving asthma population , does not significantly associate with our IBS 
population  
.                              As it has been described before, stress activates CRF-CRF1 signaling 
pathways in the brain linked with hypothalamic and pontine nuclei which stimulate the sacral 
parasympathetic nucleus and subsequently the enteric nervous system .The increased 
CRF/urocortin activtes mast cells76 & other immune cells which subsequently increases 
motility,mucus secretion,PGE2 production203.  
86 
                                    The biopsychosocial model of IBS integrates a number of 
psychosocial, motility, sensory abnormalities and abnormalities in central nervous system 
processing of visceral pain as the causes of abdominal pain and altered bowel habits.      
As  IBS  has multifactorial causes, factors other than COX2 gene polymorphism may be  
involved in this population like the above mentioned stress induced inflammatory pathway or 
Gene polymorphisms involving IL-10; 5-HTTLPR; α2-Adrenergic Receptors; Cathechol-o-
methyl transferase; G-proteins; Mitochondrial DNA  SCN5A (Na+ channel); Cannabinoid 
(CB) receptor; Neuropeptide S receptor 1 . Further studies may be undertaken in future  to  
investigate the occurrence of the polymorphisms in this population .                                 



















                         IBS is the most common disorder encountered by gastroenterologists, and is 
responsible for reduced quality of life and considerable economic burden on society. 
Presently there are no known biochemical or structural markers for identifying patients with 
IBS 
                    Attention has recently been focused on increased perception of visceral stimuli 
arising from the gastrointestinal tract wall, a phenomenon referred to as visceral 
hypersensitivity . Among the sensitising factors acting on nerve terminals at the peripheral 
level, altered interaction between the mucosal immune system and the afferent nerve 
terminals which project to the intestine is now receiving increasing attention. Low grade 
inflammation in the intestinal mucosa has been found in subgroups of patients and may be 
involved in the pathophysiology of visceral hypersensitivity, in at least some cases of IBS  
                          As COX2  gene polymorphism is associated with inflammation, this study 
was designed to investigate polymorphism in the 3-UTR region of the COX2 gene with 
occurrence of IBS.  
                    In this study homozygous COX2 TT genotype was more frequent  than TC or 
CC. This study showed that  CC polymorphism in the 3’-UTR region of the COX2 gene 
(8473) which is associated with inflammation was not significantly associated with increased 









Future Prospects of 
the Study 
 


















  This study may be further explored  in diverse and larger population, as this  COX2 gene 
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ஆராvசி  தைல~©:               
 
ெபய :                              ேததி                   : 
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NAME:       AGE / SEX:                     
 












• DM YRS  THYROID ILLNESS: 










Ht :    Wt:             Pallor / Icterus/ Pedal edema 
Vital signs: PR: BP: 
  
SYSTEMIC EXAMINATION: 
  CARDIOVASCULAR SYSTEM: 
 
   RESPIRATORY SYSTEM: 
  
   PER ABDOMEN: 
 
   CNS : 
 
IMPRESSION: 
 
 
INVESTIGATIONS: 
  
